Caydron的个人主页 - 老虎社区

Caydron

Caydron

暂无个人介绍

IP属地：未知

224关注

4粉丝

6主题

0勋章

2021-07-29

Help me out😭😭😭. Like and comment

抱歉，原内容已删除

2021-07-27

Cool. Please help like my comment

3 Warren Buffett Stocks That Are Screaming Summer Buys

2022-01-31

K

Pre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup

2021-07-28

Waiting

抱歉，原内容已删除

2021-07-28

Help like pls

抱歉，原内容已删除

2021-07-26

Cool

抱歉，原内容已删除

2021-07-24

👍😀

3 Stocks to Buy Whether or Not a Market Crash Is Near

2021-07-06

Wat

3 Top Stocks That'll Make You Richer in the Second Half of 2021 (and Beyond)

2021-07-27

Great

抱歉，原内容已删除

2021-07-24

Cool

Got $1,000? Buy These Cheap Growth Stocks Right Away

2021-07-24

👍

3 Stocks to Buy Whether or Not a Market Crash Is Near

2021-07-28

Wow

Fed Meeting Will Focus on Tapering Timeline.

2021-07-24

Looks good

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3577258181360086","uuid":"3577258181360086","gmtCreate":1614164157549,"gmtModify":1627093016042,"name":"Caydron","pinyin":"caydron","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":224,"tweetSize":13,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":6,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.02%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":633903679,"gmtCreate":1643634861324,"gmtModify":1643634861405,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/633903679","repostId":"1178215374","repostType":4,"repost":{"id":"1178215374","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643634021,"share":"https://www.laohu8.com/m/news/1178215374?lang=&edition=full","pubTime":"2022-01-31 21:00","market":"us","language":"en","title":"Pre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=1178215374","media":"Tiger Newspress","summary":"Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008","content":"<html><head></head><body><p>Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.</p><p><b>Market Snapshot</b></p><p>At 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&amp;P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.</p><p><img src=\"https://static.tigerbbs.com/7d75b4005123cd161b882e9e32b0635e\" tg-width=\"560\" tg-height=\"217\" width=\"100%\" height=\"auto\"/></p><p><b>Pre-Market Movers</b></p><p><a href=\"https://laohu8.com/S/CTXS\">Citrix</a>  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That&#39;s below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a>  (BB) – The communications software company&#39;s stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.</p><p><a href=\"https://laohu8.com/S/SPOT\">Spotify Technology S.A.</a>  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.</p><p><a href=\"https://laohu8.com/S/OTIS\">Otis Worldwide Corp</a>  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a>  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.</p><p><a href=\"https://laohu8.com/S/MPC\">Marathon</a>  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat, Inc.</a> (BYND) – Beyond Meat was double-upgraded to &#34;overweight&#34; from &#34;underweight&#34; at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company&#39;s growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a>  (ISRG) – Intuitive Surgical was upgraded to &#34;overweight&#34; from &#34;neutral&#34; at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.</p><p><a href=\"https://laohu8.com/S/NFLX\">Netflix</a> (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service&#39;s stock to &#34;buy&#34; from &#34;neutral.&#34; Citi said that following the recent sell-off, prevailing equity values don&#39;t reflect material subscriber growth prospects or improving subscriber economics beyond 2023.</p><p><a href=\"https://laohu8.com/S/ALGN\">Align Technology</a>  (ALGN), <a href=\"https://laohu8.com/S/NVST\">Envista Holdings</a>  (NVST) – The maker of Invisalign dental braces was rated &#34;overweight&#34; in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.</p><p><b>Market News</b></p><p>Vodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone&#39;s digital innovation and R&amp;D centre in Malaga, which opened on Monday.</p><p>Norway&#39;s Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.</p><p>Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.</p><p>ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.</p><p>Kalera To Go Public On Nasdaq Through Merger With <a href=\"https://laohu8.com/S/RICOU\">Agrico Acquisition Corp</a>.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.</p><p>Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech&#39;s (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-31 21:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.</p><p><b>Market Snapshot</b></p><p>At 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&amp;P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.</p><p><img src=\"https://static.tigerbbs.com/7d75b4005123cd161b882e9e32b0635e\" tg-width=\"560\" tg-height=\"217\" width=\"100%\" height=\"auto\"/></p><p><b>Pre-Market Movers</b></p><p><a href=\"https://laohu8.com/S/CTXS\">Citrix</a>  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That&#39;s below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a>  (BB) – The communications software company&#39;s stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.</p><p><a href=\"https://laohu8.com/S/SPOT\">Spotify Technology S.A.</a>  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.</p><p><a href=\"https://laohu8.com/S/OTIS\">Otis Worldwide Corp</a>  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a>  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.</p><p><a href=\"https://laohu8.com/S/MPC\">Marathon</a>  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat, Inc.</a> (BYND) – Beyond Meat was double-upgraded to &#34;overweight&#34; from &#34;underweight&#34; at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company&#39;s growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a>  (ISRG) – Intuitive Surgical was upgraded to &#34;overweight&#34; from &#34;neutral&#34; at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.</p><p><a href=\"https://laohu8.com/S/NFLX\">Netflix</a> (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service&#39;s stock to &#34;buy&#34; from &#34;neutral.&#34; Citi said that following the recent sell-off, prevailing equity values don&#39;t reflect material subscriber growth prospects or improving subscriber economics beyond 2023.</p><p><a href=\"https://laohu8.com/S/ALGN\">Align Technology</a>  (ALGN), <a href=\"https://laohu8.com/S/NVST\">Envista Holdings</a>  (NVST) – The maker of Invisalign dental braces was rated &#34;overweight&#34; in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.</p><p><b>Market News</b></p><p>Vodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone&#39;s digital innovation and R&amp;D centre in Malaga, which opened on Monday.</p><p>Norway&#39;s Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.</p><p>Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.</p><p>ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.</p><p>Kalera To Go Public On Nasdaq Through Merger With <a href=\"https://laohu8.com/S/RICOU\">Agrico Acquisition Corp</a>.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.</p><p>Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech&#39;s (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178215374","content_text":"Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.Market SnapshotAt 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.Pre-Market MoversCitrix  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That's below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.BlackBerry  (BB) – The communications software company's stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.Spotify Technology S.A.  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.Otis Worldwide Corp  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.Walgreens Boots Alliance  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.Marathon  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.Beyond Meat, Inc. (BYND) – Beyond Meat was double-upgraded to \"overweight\" from \"underweight\" at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company's growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.Intuitive Surgical  (ISRG) – Intuitive Surgical was upgraded to \"overweight\" from \"neutral\" at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.Netflix (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service's stock to \"buy\" from \"neutral.\" Citi said that following the recent sell-off, prevailing equity values don't reflect material subscriber growth prospects or improving subscriber economics beyond 2023.Align Technology  (ALGN), Envista Holdings  (NVST) – The maker of Invisalign dental braces was rated \"overweight\" in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.Market NewsVodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone's digital innovation and R&D centre in Malaga, which opened on Monday.Norway's Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.Kalera To Go Public On Nasdaq Through Merger With Agrico Acquisition Corp.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech's (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.","news_type":1},"isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801770555,"gmtCreate":1627538886377,"gmtModify":1633763982798,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Help me out😭😭😭. Like and comment&nbsp;","listText":"Help me out😭😭😭. Like and comment&nbsp;","text":"Help me out😭😭😭. Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801770555","repostId":"2154861924","repostType":4,"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801379429,"gmtCreate":1627485072361,"gmtModify":1633764527361,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801379429","repostId":"1102922788","repostType":4,"repost":{"id":"1102922788","kind":"news","pubTimestamp":1627479526,"share":"https://www.laohu8.com/m/news/1102922788?lang=&edition=full","pubTime":"2021-07-28 21:38","market":"us","language":"en","title":"Fed Meeting Will Focus on Tapering Timeline.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102922788","media":"The Wall Street Journal","summary":"Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\n","content":"<p>Officials are looking to forge consensus on how and when to eventually reduce their asset purchases</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b506b5e7aef3659e57731a13007a3078\" tg-width=\"1290\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Fed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised ample notice before reducing purchases of securities.</span></p>\n<p>Federal Reserve officials are set to resume deliberations Wednesday about how and when to begin&nbsp;paring their asset purchases&nbsp;amid an economic rebound clouded by supply-chain bottlenecks and rising Covid-19 cases.</p>\n<p>The central bank at the end of last year said it would continue to purchase $120 billion in Treasurys and mortgage-backed securities monthly until officials deemed they had achieved “substantial further progress” toward their goals of low unemployment and inflation reaching their 2% goal.</p>\n<p>The Fed will release its policy statement at 2 p.m. EDT. Most of the focus is likely to center on Chairman Jerome Powell’s news conference at 2:30 p.m. Here’s what to watch:</p>\n<p><b>Taper timing</b></p>\n<p>Officials are likely to receive a formal staff briefing around when to start paring their monthly purchases of $80 billion in Treasury securities and $40 billion in mortgage securities, and how quickly to reduce, or taper, them.</p>\n<p>The Fed began buying large quantities of the securities in March 2020, when the Covid-19 pandemic triggered a near-meltdown in financial markets. With the Fed’s short-term interest rate at zero, the purchases are designed to provide additional stimulus by holding down long-term interest rates.</p>\n<p>Some officials are concerned&nbsp;that a burst of inflation this year from bottlenecks associated with reopening the economy will prove more durable than previously anticipated. These policy makers are eager to start the taper, in part because they and their colleagues have said they aren’t likely to consider raising interest rates from near zero until they are done tapering the asset purchases.</p>\n<p>Another camp thinks recent&nbsp;price pressures will subside&nbsp;and could leave the Fed in the same position that it faced for much of the past decade, in which global forces kept inflation below 2% even with historically low interest rates. They are worried that accelerating plans to wind down the asset purchases could raise questions among investors about the Fed’s commitment to achieving its economic goals.</p>\n<p>Because Mr. Powell has pledged&nbsp;to provide ample notice&nbsp;to financial markets before the Fed starts tapering&nbsp;to avoid catching investors by surprise, the central bank looks unlikely to start the process now or at its next meeting in September. Mr. Powell’s press conference will be heavily scrutinized for clues on how officials judge recent economic progress. In April, he said the Fed was “a long way from” its tapering goals, and he characterized the economy as “still a ways off” from them in June.</p>\n<p><b>Purchase pace</b></p>\n<p>Officials also must consider the pace of any reductions. Some officials have discussed concluding the purchases around October 2022 so they could lift rates soon thereafter if the recovery is stronger or inflation is higher than now anticipated.</p>\n<p>During a prior asset-purchase program that ended in 2014, the Fed shrank its purchases in modest, equal amounts over the course of 10 months. It then waited another 14 months before raising interest rates.</p>\n<p>Another tactical question centers on whether&nbsp;to reduce the pace of Treasurys and mortgage-backed securities equally. Some officials have raised concerns about rising home prices and are pressing to stop purchases of mortgage bonds sooner.</p>\n<p>But Mr. Powell and other officials have poured cold water on those concerns in recent weeks. They have said mortgage buying, by purchasing longer-dated assets, provides a way to more broadly stimulate the economy and isn’t focused squarely on housing markets.</p>\n<p>“If the housing market has you really worried, that’s an argument for just tapering everything sooner and faster,” said William English, a former senior Fed economist who is now a professor at the Yale School of Management.</p>\n<p><b>Inflation outlook</b></p>\n<p>For a third straight month in June,inflation ran hotter&nbsp;than many economists had expected. The Labor Department’s consumer-price index increased 5.4% from a year ago, the highest 12-month rate since August 2008.</p>\n<p>Mr. Powell said two weeks ago that&nbsp;many of the elevated price pressures&nbsp;can still be traced to goods and services affected by supply-chain bottlenecks and other pandemic-driven upheaval. As a result, he said it would be too soon for the Fed to abandon its earlier expectation that prices will return to their 2% target on their own and to raise rates to cool down demand and reduce inflation faster.</p>\n<p>But Mr. Powell could face questions over how long the central bank and its 12-member rate-setting committee feels it would take to revisit their projections. Price pressures in some sectors of the economy where inflation had been subdued over the past year, including residential rents, have picked in recent months.</p>\n<p><b>Delta variant</b></p>\n<p>Mr. Powell is also likely to be pressed on how the recent increase in Covid-19 cases among unvaccinated populations could reshape the central bank’s growth forecasts for the rest of the year. While a return to shutdowns and other state-mandated restrictions on activity seem less likely than a year ago, increased hesitancy on the part of consumers to return to normal spending routines could complicate the economic outlook.</p>\n<p>Since Fed officials last met in June, government-bond prices have jumped, a sign that investors are less confident about long-term growth prospects and less worried about inflation.</p>\n<p>Yields, which rise when bond prices fall, climbed sharply earlier in the year, lifted by expectations that vaccinations and fiscal stimulus would spur an economic boom. After hitting a 13-month high of 1.75% at the end of March, the 10-year Treasury yield has declined—to 1.57% on June 16, after the Fed concluded its previous meeting, and to 1.24%, a five-month low, when the Fed’s meeting began on Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Meeting Will Focus on Tapering Timeline.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Meeting Will Focus on Tapering Timeline.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-28 21:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\nFed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised...</p>\n\n<a href=\"https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102922788","content_text":"Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\nFed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised ample notice before reducing purchases of securities.\nFederal Reserve officials are set to resume deliberations Wednesday about how and when to begin paring their asset purchases amid an economic rebound clouded by supply-chain bottlenecks and rising Covid-19 cases.\nThe central bank at the end of last year said it would continue to purchase $120 billion in Treasurys and mortgage-backed securities monthly until officials deemed they had achieved “substantial further progress” toward their goals of low unemployment and inflation reaching their 2% goal.\nThe Fed will release its policy statement at 2 p.m. EDT. Most of the focus is likely to center on Chairman Jerome Powell’s news conference at 2:30 p.m. Here’s what to watch:\nTaper timing\nOfficials are likely to receive a formal staff briefing around when to start paring their monthly purchases of $80 billion in Treasury securities and $40 billion in mortgage securities, and how quickly to reduce, or taper, them.\nThe Fed began buying large quantities of the securities in March 2020, when the Covid-19 pandemic triggered a near-meltdown in financial markets. With the Fed’s short-term interest rate at zero, the purchases are designed to provide additional stimulus by holding down long-term interest rates.\nSome officials are concerned that a burst of inflation this year from bottlenecks associated with reopening the economy will prove more durable than previously anticipated. These policy makers are eager to start the taper, in part because they and their colleagues have said they aren’t likely to consider raising interest rates from near zero until they are done tapering the asset purchases.\nAnother camp thinks recent price pressures will subside and could leave the Fed in the same position that it faced for much of the past decade, in which global forces kept inflation below 2% even with historically low interest rates. They are worried that accelerating plans to wind down the asset purchases could raise questions among investors about the Fed’s commitment to achieving its economic goals.\nBecause Mr. Powell has pledged to provide ample notice to financial markets before the Fed starts tapering to avoid catching investors by surprise, the central bank looks unlikely to start the process now or at its next meeting in September. Mr. Powell’s press conference will be heavily scrutinized for clues on how officials judge recent economic progress. In April, he said the Fed was “a long way from” its tapering goals, and he characterized the economy as “still a ways off” from them in June.\nPurchase pace\nOfficials also must consider the pace of any reductions. Some officials have discussed concluding the purchases around October 2022 so they could lift rates soon thereafter if the recovery is stronger or inflation is higher than now anticipated.\nDuring a prior asset-purchase program that ended in 2014, the Fed shrank its purchases in modest, equal amounts over the course of 10 months. It then waited another 14 months before raising interest rates.\nAnother tactical question centers on whether to reduce the pace of Treasurys and mortgage-backed securities equally. Some officials have raised concerns about rising home prices and are pressing to stop purchases of mortgage bonds sooner.\nBut Mr. Powell and other officials have poured cold water on those concerns in recent weeks. They have said mortgage buying, by purchasing longer-dated assets, provides a way to more broadly stimulate the economy and isn’t focused squarely on housing markets.\n“If the housing market has you really worried, that’s an argument for just tapering everything sooner and faster,” said William English, a former senior Fed economist who is now a professor at the Yale School of Management.\nInflation outlook\nFor a third straight month in June,inflation ran hotter than many economists had expected. The Labor Department’s consumer-price index increased 5.4% from a year ago, the highest 12-month rate since August 2008.\nMr. Powell said two weeks ago that many of the elevated price pressures can still be traced to goods and services affected by supply-chain bottlenecks and other pandemic-driven upheaval. As a result, he said it would be too soon for the Fed to abandon its earlier expectation that prices will return to their 2% target on their own and to raise rates to cool down demand and reduce inflation faster.\nBut Mr. Powell could face questions over how long the central bank and its 12-member rate-setting committee feels it would take to revisit their projections. Price pressures in some sectors of the economy where inflation had been subdued over the past year, including residential rents, have picked in recent months.\nDelta variant\nMr. Powell is also likely to be pressed on how the recent increase in Covid-19 cases among unvaccinated populations could reshape the central bank’s growth forecasts for the rest of the year. While a return to shutdowns and other state-mandated restrictions on activity seem less likely than a year ago, increased hesitancy on the part of consumers to return to normal spending routines could complicate the economic outlook.\nSince Fed officials last met in June, government-bond prices have jumped, a sign that investors are less confident about long-term growth prospects and less worried about inflation.\nYields, which rise when bond prices fall, climbed sharply earlier in the year, lifted by expectations that vaccinations and fiscal stimulus would spur an economic boom. After hitting a 13-month high of 1.75% at the end of March, the 10-year Treasury yield has declined—to 1.57% on June 16, after the Fed concluded its previous meeting, and to 1.24%, a five-month low, when the Fed’s meeting began on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801379154,"gmtCreate":1627485051478,"gmtModify":1633764527605,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Help like pls","listText":"Help like pls","text":"Help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801379154","repostId":"1179923360","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803928733,"gmtCreate":1627402537822,"gmtModify":1633765325132,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Waiting","listText":"Waiting","text":"Waiting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/803928733","repostId":"1108849761","repostType":4,"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800704067,"gmtCreate":1627316261959,"gmtModify":1633766174288,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/800704067","repostId":"1191215576","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800705614,"gmtCreate":1627316233438,"gmtModify":1633766174533,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool. Please help like my comment","listText":"Cool. Please help like my comment","text":"Cool. Please help like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/800705614","repostId":"2154957883","repostType":4,"repost":{"id":"2154957883","kind":"highlight","pubTimestamp":1627298804,"share":"https://www.laohu8.com/m/news/2154957883?lang=&edition=full","pubTime":"2021-07-26 19:26","market":"us","language":"en","title":"3 Warren Buffett Stocks That Are Screaming Summer Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2154957883","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails is a moneymaking proposition.","content":"<p>If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than Warren Buffett's track record. As CEO of <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B), Buffett has led his company to an average annual return of 20% since taking the helm in 1965. Through 2020, this worked out to an aggregate return of more than 2,800,000%, and it's created over $500 billion in value for Berkshire Hathaway's shareholders.</p>\n<p>Like all investors, Buffett isn't infallible. He's going to make mistakes from time to time. But he and his investing team have a knack for locating companies with plain-as-day sustainable competitive advantages. As the summer temperatures heat up, the following three Warren Buffett stocks stand out as screaming buys.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e92116e97f06291ec28eda85974acb1b\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</span></p>\n<h2>Amazon</h2>\n<p>Was there ever any doubt that <b>Amazon</b> (NASDAQ:AMZN) wouldn't be a screaming buy? Even though it's a stock that was added by Buffett's investing lieutenants (Todd Combs and Ted Weschler) and not the Oracle of Omaha himself, it's nevertheless <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most attractive holdings in Berkshire Hathaway's portfolio.</p>\n<p>As a lot of folks are probably aware, Amazon is the king of the hill when it comes online commerce. This year, the company's marketplace is expected to control roughly $0.40 of every $1 spent online in the United States, according to an April report from eMarketer. The next closest competitor is <b>Walmart</b>, which'll handle about 7% of all U.S. online retail.</p>\n<p>Amazon has been able to pivot its incredible online retail success into signing up more than 200 million people worldwide to a Prime membership. While Prime members enjoy free two-day shipping and access to streaming content, the lure for Amazon is that Prime fees generate tens of billions in added revenue that it can use to undercut brick-and-mortar retailers on price and buoy its margins.</p>\n<p>What you might not realize about Amazon is that it's overwhelmingly dominant in a second industry, as well. Amazon Web Services (AWS) brought in 32% of global cloud infrastructure spending in the first quarter, per Canalys. Cloud infrastructure is still, arguably, in the early innings of its expansion, and it's a considerably higher margin segment for Amazon than retail or advertising. Thus, AWS is going to send Amazon's operating cash flow to the moon as it grows into a larger percentage of total sales.</p>\n<p>For the past 11 years, Wall Street and investors have consistently valued Amazon at a multiple of 23 to 37 times its cash flow. If this range remains intact, a near-tripling in the stock is possible by mid-decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/146ce4600b7c22643629193901a4328a\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bristol Myers Squibb</h2>\n<p>If value investing suits you better, pharmaceutical stock <b>Bristol Myers Squibb</b> (NYSE:BMY) has the makings of a screaming summer buy.</p>\n<p>The great thing about healthcare stocks is they're highly defensive. Since we don't get to choose when we get sick or what ailments we develop, there's a consistent demand for healthcare services, drugs, and devices, no matter how well or poorly the U.S. and global economy are performing.</p>\n<p>What makes Bristol Myers Squibb such a special company is its organic growth potential and astute dealmaking. To tackle the former, Bristol Myers and <b>Pfizer</b>&nbsp;co-developed the world's leading oral anticoagulant, Eliquis, which looks to be on pace for more than $10 billion in sales this year for Bristol. There's also cancer immunotherapy Opdivo, which is being examined in dozens of ongoing clinical trials. Opdivo is already bringing in about $7 billion annually, and could push higher with continued label expansion opportunities. All told, eight brand-name therapies are on track for at least $1.2 billion in annual sales this year, based on extrapolated Q1 sales totals.</p>\n<p>On the dealmaking front, Bristol Myers Squibb hit a home run when it acquired cancer and immunology drugmaker Celgene in 2019. Celgene's superstar is multiple myeloma drug Revlimid, which brought in $12.1 billion in sales last year and has been growing by a double-digit percentage annually for more than a decade. Longer duration of use, label expansions, improved cancer screening diagnostics, and strong pricing power have all fueled Revlimid's growth. Best of all, it's protected from a large wave of generic competition until the end of January 2026. This means Bristol Myers will be basking in significant cash flow for another 4.5 years.</p>\n<p>In a world where valuation premiums are soaring, it seems unjust that a company so profitable should be valued at only 8.5 times Wall Street's consensus earnings for 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8abdae403dddfa42107e06ea5bfddf39\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>General Motors</h2>\n<p>Lastly, if you want a screaming summer buy that's near and dear to Warren Buffett's investment philosophy, consider auto stock <b>General Motors</b> (NYSE:GM).</p>\n<p>Historically, auto stocks are slow-growing companies that sports high levels of debt and are valued at price-to-earnings multiples that are well below the average S&amp;P 500 company. But General Motors and its peers are the verge of taking advantage of an epic vehicle replacement cycle as consumers and businesses make the shift to electric vehicles (EV).</p>\n<p>Initially, General Motors was going to devote $20 billion to EV investment by mid-decade. However, in November, the company upped its expected outlay to $27 billion by 2025, with the ultimate goal of bringing 30 new EVs to market globally. Some of this capital will be used to bring EVs to market earlier than initially planned, as well as to develop GM's battery technology. With IHS <a href=\"https://laohu8.com/S/MRKT\">Markit</a> forecasting that 10% of all U.S. vehicle sales will be electric by 2025 (up from 1.8% in 2020), a hefty investment in this changing landscape makes sense for GM.</p>\n<p>Equally important are the company's ambitions overseas -- especially in China, the largest auto market in the world. By 2035, the Society of Automotive Engineers of China anticipates that half of all vehicle sales will be some form of alternative energy. Through the first-half of 2021, GM delivered more than 1.5 million vehicles in China.&nbsp; With an established presence, existing infrastructure, and well-known branding, GM has a real shot at becoming an EV leader in China.</p>\n<p>A forward-year price-to-earnings ratio of 8 simply doesn't convey the multi-decade growth opportunity that's on GM's doorstep.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks That Are Screaming Summer Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks That Are Screaming Summer Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-26 19:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BMY":"施贵宝","BRK.B":"伯克希尔B","BRK.A":"伯克希尔","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154957883","content_text":"If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than Warren Buffett's track record. As CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), Buffett has led his company to an average annual return of 20% since taking the helm in 1965. Through 2020, this worked out to an aggregate return of more than 2,800,000%, and it's created over $500 billion in value for Berkshire Hathaway's shareholders.\nLike all investors, Buffett isn't infallible. He's going to make mistakes from time to time. But he and his investing team have a knack for locating companies with plain-as-day sustainable competitive advantages. As the summer temperatures heat up, the following three Warren Buffett stocks stand out as screaming buys.\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nAmazon\nWas there ever any doubt that Amazon (NASDAQ:AMZN) wouldn't be a screaming buy? Even though it's a stock that was added by Buffett's investing lieutenants (Todd Combs and Ted Weschler) and not the Oracle of Omaha himself, it's nevertheless one of the most attractive holdings in Berkshire Hathaway's portfolio.\nAs a lot of folks are probably aware, Amazon is the king of the hill when it comes online commerce. This year, the company's marketplace is expected to control roughly $0.40 of every $1 spent online in the United States, according to an April report from eMarketer. The next closest competitor is Walmart, which'll handle about 7% of all U.S. online retail.\nAmazon has been able to pivot its incredible online retail success into signing up more than 200 million people worldwide to a Prime membership. While Prime members enjoy free two-day shipping and access to streaming content, the lure for Amazon is that Prime fees generate tens of billions in added revenue that it can use to undercut brick-and-mortar retailers on price and buoy its margins.\nWhat you might not realize about Amazon is that it's overwhelmingly dominant in a second industry, as well. Amazon Web Services (AWS) brought in 32% of global cloud infrastructure spending in the first quarter, per Canalys. Cloud infrastructure is still, arguably, in the early innings of its expansion, and it's a considerably higher margin segment for Amazon than retail or advertising. Thus, AWS is going to send Amazon's operating cash flow to the moon as it grows into a larger percentage of total sales.\nFor the past 11 years, Wall Street and investors have consistently valued Amazon at a multiple of 23 to 37 times its cash flow. If this range remains intact, a near-tripling in the stock is possible by mid-decade.\nImage source: Getty Images.\nBristol Myers Squibb\nIf value investing suits you better, pharmaceutical stock Bristol Myers Squibb (NYSE:BMY) has the makings of a screaming summer buy.\nThe great thing about healthcare stocks is they're highly defensive. Since we don't get to choose when we get sick or what ailments we develop, there's a consistent demand for healthcare services, drugs, and devices, no matter how well or poorly the U.S. and global economy are performing.\nWhat makes Bristol Myers Squibb such a special company is its organic growth potential and astute dealmaking. To tackle the former, Bristol Myers and Pfizer co-developed the world's leading oral anticoagulant, Eliquis, which looks to be on pace for more than $10 billion in sales this year for Bristol. There's also cancer immunotherapy Opdivo, which is being examined in dozens of ongoing clinical trials. Opdivo is already bringing in about $7 billion annually, and could push higher with continued label expansion opportunities. All told, eight brand-name therapies are on track for at least $1.2 billion in annual sales this year, based on extrapolated Q1 sales totals.\nOn the dealmaking front, Bristol Myers Squibb hit a home run when it acquired cancer and immunology drugmaker Celgene in 2019. Celgene's superstar is multiple myeloma drug Revlimid, which brought in $12.1 billion in sales last year and has been growing by a double-digit percentage annually for more than a decade. Longer duration of use, label expansions, improved cancer screening diagnostics, and strong pricing power have all fueled Revlimid's growth. Best of all, it's protected from a large wave of generic competition until the end of January 2026. This means Bristol Myers will be basking in significant cash flow for another 4.5 years.\nIn a world where valuation premiums are soaring, it seems unjust that a company so profitable should be valued at only 8.5 times Wall Street's consensus earnings for 2022.\nImage source: Getty Images.\nGeneral Motors\nLastly, if you want a screaming summer buy that's near and dear to Warren Buffett's investment philosophy, consider auto stock General Motors (NYSE:GM).\nHistorically, auto stocks are slow-growing companies that sports high levels of debt and are valued at price-to-earnings multiples that are well below the average S&P 500 company. But General Motors and its peers are the verge of taking advantage of an epic vehicle replacement cycle as consumers and businesses make the shift to electric vehicles (EV).\nInitially, General Motors was going to devote $20 billion to EV investment by mid-decade. However, in November, the company upped its expected outlay to $27 billion by 2025, with the ultimate goal of bringing 30 new EVs to market globally. Some of this capital will be used to bring EVs to market earlier than initially planned, as well as to develop GM's battery technology. With IHS Markit forecasting that 10% of all U.S. vehicle sales will be electric by 2025 (up from 1.8% in 2020), a hefty investment in this changing landscape makes sense for GM.\nEqually important are the company's ambitions overseas -- especially in China, the largest auto market in the world. By 2035, the Society of Automotive Engineers of China anticipates that half of all vehicle sales will be some form of alternative energy. Through the first-half of 2021, GM delivered more than 1.5 million vehicles in China.  With an established presence, existing infrastructure, and well-known branding, GM has a real shot at becoming an EV leader in China.\nA forward-year price-to-earnings ratio of 8 simply doesn't convey the multi-decade growth opportunity that's on GM's doorstep.","news_type":1},"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177278533,"gmtCreate":1627229964922,"gmtModify":1633767017705,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/177278533","repostId":"2153878189","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174983815,"gmtCreate":1627057811137,"gmtModify":1633768340277,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Looks good","listText":"Looks good","text":"Looks good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174983815","repostId":"2153998479","repostType":4,"repost":{"id":"2153998479","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627050407,"share":"https://www.laohu8.com/m/news/2153998479?lang=&edition=full","pubTime":"2021-07-23 22:26","market":"fut","language":"en","title":"Gold dips as yields perk up, dollar strengthens","url":"https://stock-news.laohu8.com/highlight/detail?id=2153998479","media":"Reuters","summary":"Silver on track for third weekly fall\nBullion down 0.7% this week\n\nJuly 23 (Reuters) - Gold struggle","content":"<ul>\n <li>Silver on track for third weekly fall</li>\n <li>Bullion down 0.7% this week</li>\n</ul>\n<p>July 23 (Reuters) - Gold struggled for traction and was heading for a weekly dip on Friday as a stronger dollar, firmer yields and equity markets chipped away at its appeal.</p>\n<p>Spot gold fell 0.4% to $1,799.84 per ounce by 10:04 pm EDT (1404 GMT). U.S. gold futures slipped 0.2% to $1,801.00.</p>\n<p>Bullion has shed 0.7% this week after briefly moving towards last week's <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month peak as fears over rising delta variant COVID-19 cases have eased, driving investors to equities as risk appetite returned.</p>\n<p>\"The gold market is seeking out a fresh fundamental driver and there really isn't one,\" said Jim Wyckoff, senior analyst with Kitco Metals, noting that weaker real yields and a jump in COVID-19 cases were not enough to move prices higher.</p>\n<p>\"Technical traders are taking over because of the lack of fundamentals and gold's near-term technical posture has turned negative, inviting some traders to short the market.\"</p>\n<p>Heaping pressure on the metal, was a stronger dollar index which held close to a 3-1/2-month peak and firmer benchmark treasury yields.</p>\n<p>Higher yields tend to weigh on gold which pays no interest as it translates into an increased opportunity cost of holding the metal.</p>\n<p>Market focus now turns to next week's U.S. Federal Reserve meeting for more clues on monetary policy after the European Central Bank on Thursday pledged to keep interest rates at record lows for some time.</p>\n<p>\"This means that negative interest rates will remain a permanent feature for now and this should increase demand for gold noticeably in the medium to longer term,\" Commerzbank said in a note.</p>\n<p>Silver fell 1.4% to $25.09 per ounce, and was set for a third consecutive weekly fall.</p>\n<p>Platinum slipped 2.6% to $1,064.17, and palladium&nbsp;shed 0.4% to $2,707.63.</p>\n<p>(Reporting by Nakul Iyer in Bengaluru; Editing by Andrea Ricci)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold dips as yields perk up, dollar strengthens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold dips as yields perk up, dollar strengthens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-23 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Silver on track for third weekly fall</li>\n <li>Bullion down 0.7% this week</li>\n</ul>\n<p>July 23 (Reuters) - Gold struggled for traction and was heading for a weekly dip on Friday as a stronger dollar, firmer yields and equity markets chipped away at its appeal.</p>\n<p>Spot gold fell 0.4% to $1,799.84 per ounce by 10:04 pm EDT (1404 GMT). U.S. gold futures slipped 0.2% to $1,801.00.</p>\n<p>Bullion has shed 0.7% this week after briefly moving towards last week's <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month peak as fears over rising delta variant COVID-19 cases have eased, driving investors to equities as risk appetite returned.</p>\n<p>\"The gold market is seeking out a fresh fundamental driver and there really isn't one,\" said Jim Wyckoff, senior analyst with Kitco Metals, noting that weaker real yields and a jump in COVID-19 cases were not enough to move prices higher.</p>\n<p>\"Technical traders are taking over because of the lack of fundamentals and gold's near-term technical posture has turned negative, inviting some traders to short the market.\"</p>\n<p>Heaping pressure on the metal, was a stronger dollar index which held close to a 3-1/2-month peak and firmer benchmark treasury yields.</p>\n<p>Higher yields tend to weigh on gold which pays no interest as it translates into an increased opportunity cost of holding the metal.</p>\n<p>Market focus now turns to next week's U.S. Federal Reserve meeting for more clues on monetary policy after the European Central Bank on Thursday pledged to keep interest rates at record lows for some time.</p>\n<p>\"This means that negative interest rates will remain a permanent feature for now and this should increase demand for gold noticeably in the medium to longer term,\" Commerzbank said in a note.</p>\n<p>Silver fell 1.4% to $25.09 per ounce, and was set for a third consecutive weekly fall.</p>\n<p>Platinum slipped 2.6% to $1,064.17, and palladium&nbsp;shed 0.4% to $2,707.63.</p>\n<p>(Reporting by Nakul Iyer in Bengaluru; Editing by Andrea Ricci)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"159934":"黄金ETF","518880":"黄金ETF","GLD":"SPDR黄金ETF","DUST":"二倍做空黄金矿业指数ETF-Direxion","IAU":"黄金信托ETF(iShares)","NUGT":"二倍做多黄金矿业指数ETF-Direxion","GDX":"黄金矿业ETF-VanEck"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153998479","content_text":"Silver on track for third weekly fall\nBullion down 0.7% this week\n\nJuly 23 (Reuters) - Gold struggled for traction and was heading for a weekly dip on Friday as a stronger dollar, firmer yields and equity markets chipped away at its appeal.\nSpot gold fell 0.4% to $1,799.84 per ounce by 10:04 pm EDT (1404 GMT). U.S. gold futures slipped 0.2% to $1,801.00.\nBullion has shed 0.7% this week after briefly moving towards last week's one-month peak as fears over rising delta variant COVID-19 cases have eased, driving investors to equities as risk appetite returned.\n\"The gold market is seeking out a fresh fundamental driver and there really isn't one,\" said Jim Wyckoff, senior analyst with Kitco Metals, noting that weaker real yields and a jump in COVID-19 cases were not enough to move prices higher.\n\"Technical traders are taking over because of the lack of fundamentals and gold's near-term technical posture has turned negative, inviting some traders to short the market.\"\nHeaping pressure on the metal, was a stronger dollar index which held close to a 3-1/2-month peak and firmer benchmark treasury yields.\nHigher yields tend to weigh on gold which pays no interest as it translates into an increased opportunity cost of holding the metal.\nMarket focus now turns to next week's U.S. Federal Reserve meeting for more clues on monetary policy after the European Central Bank on Thursday pledged to keep interest rates at record lows for some time.\n\"This means that negative interest rates will remain a permanent feature for now and this should increase demand for gold noticeably in the medium to longer term,\" Commerzbank said in a note.\nSilver fell 1.4% to $25.09 per ounce, and was set for a third consecutive weekly fall.\nPlatinum slipped 2.6% to $1,064.17, and palladium shed 0.4% to $2,707.63.\n(Reporting by Nakul Iyer in Bengaluru; Editing by Andrea Ricci)","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174917552,"gmtCreate":1627057631176,"gmtModify":1633768341929,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174917552","repostId":"2153751984","repostType":4,"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174914269,"gmtCreate":1627057543351,"gmtModify":1633768342254,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"👍😀","listText":"👍😀","text":"👍😀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174914269","repostId":"2153983997","repostType":4,"repost":{"id":"2153983997","kind":"highlight","pubTimestamp":1627045860,"share":"https://www.laohu8.com/m/news/2153983997?lang=&edition=full","pubTime":"2021-07-23 21:11","market":"us","language":"en","title":"3 Stocks to Buy Whether or Not a Market Crash Is Near","url":"https://stock-news.laohu8.com/highlight/detail?id=2153983997","media":"Motley Fool","summary":"Maybe the market is about to crash, and maybe it isn't. These stocks look like good picks either way.","content":"<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.</p>\n<p>One of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.</p>\n<p>If you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.</p>\n<p><img src=\"https://static.tigerbbs.com/3105d12ec8b203883b5e91a709172e8b\" tg-width=\"700\" tg-height=\"514\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>BioNTech</h3>\n<p>I personally don't think a stock market crash is just around the corner. If <a href=\"https://laohu8.com/S/AONE.U\">one</a> is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right,&nbsp;<b>BioNTech</b> (NASDAQ:BNTX) should soar if the market crashes.</p>\n<p>A massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest winners in the group.</p>\n<p>BioNTech and its partner <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.</p>\n<p>What if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.</p>\n<h3><a href=\"https://laohu8.com/S/DG\">Dollar General</a></h3>\n<p>I've maintained for a long time that&nbsp;<b>Dollar <a href=\"https://laohu8.com/S/BGC\">General</a></b> (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.</p>\n<p><img src=\"https://static.tigerbbs.com/b0e75aa27d2d22b4296c80687da5be97\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"></p>\n<p>DG data by YCharts.</p>\n<p>Shares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.</p>\n<p>During uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.</p>\n<p>Even when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the <b>S&amp;P 500</b> index did in the five years leading up to 2020 when the market was roaring.</p>\n<p>I think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.</p>\n<h3>Viatris</h3>\n<p>There are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that&nbsp;<b>Viatris</b> (NASDAQ:VTRS) qualifies on both of these criteria.</p>\n<p>Viatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.</p>\n<p>The stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.</p>\n<p>Granted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy Whether or Not a Market Crash Is Near</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy Whether or Not a Market Crash Is Near\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","VTRS":"Viatris Inc.","DG":"美国达乐公司"},"source_url":"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153983997","content_text":"Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.\nOne of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.\nIf you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.\n\nImage source: Getty Images.\nBioNTech\nI personally don't think a stock market crash is just around the corner. If one is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right, BioNTech (NASDAQ:BNTX) should soar if the market crashes.\nA massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be one of the biggest winners in the group.\nBioNTech and its partner Pfizer (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.\nWhat if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.\nDollar General\nI've maintained for a long time that Dollar General (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.\n\nDG data by YCharts.\nShares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.\nDuring uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.\nEven when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the S&P 500 index did in the five years leading up to 2020 when the market was roaring.\nI think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.\nViatris\nThere are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that Viatris (NASDAQ:VTRS) qualifies on both of these criteria.\nViatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.\nThe stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.\nGranted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174915258,"gmtCreate":1627057508774,"gmtModify":1633768343069,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174915258","repostId":"2153983997","repostType":4,"repost":{"id":"2153983997","kind":"highlight","pubTimestamp":1627045860,"share":"https://www.laohu8.com/m/news/2153983997?lang=&edition=full","pubTime":"2021-07-23 21:11","market":"us","language":"en","title":"3 Stocks to Buy Whether or Not a Market Crash Is Near","url":"https://stock-news.laohu8.com/highlight/detail?id=2153983997","media":"Motley Fool","summary":"Maybe the market is about to crash, and maybe it isn't. These stocks look like good picks either way.","content":"<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.</p>\n<p>One of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.</p>\n<p>If you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.</p>\n<p><img src=\"https://static.tigerbbs.com/3105d12ec8b203883b5e91a709172e8b\" tg-width=\"700\" tg-height=\"514\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>BioNTech</h3>\n<p>I personally don't think a stock market crash is just around the corner. If <a href=\"https://laohu8.com/S/AONE.U\">one</a> is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right,&nbsp;<b>BioNTech</b> (NASDAQ:BNTX) should soar if the market crashes.</p>\n<p>A massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest winners in the group.</p>\n<p>BioNTech and its partner <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.</p>\n<p>What if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.</p>\n<h3><a href=\"https://laohu8.com/S/DG\">Dollar General</a></h3>\n<p>I've maintained for a long time that&nbsp;<b>Dollar <a href=\"https://laohu8.com/S/BGC\">General</a></b> (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.</p>\n<p><img src=\"https://static.tigerbbs.com/b0e75aa27d2d22b4296c80687da5be97\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"></p>\n<p>DG data by YCharts.</p>\n<p>Shares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.</p>\n<p>During uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.</p>\n<p>Even when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the <b>S&amp;P 500</b> index did in the five years leading up to 2020 when the market was roaring.</p>\n<p>I think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.</p>\n<h3>Viatris</h3>\n<p>There are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that&nbsp;<b>Viatris</b> (NASDAQ:VTRS) qualifies on both of these criteria.</p>\n<p>Viatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.</p>\n<p>The stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.</p>\n<p>Granted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy Whether or Not a Market Crash Is Near</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy Whether or Not a Market Crash Is Near\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","VTRS":"Viatris Inc.","DG":"美国达乐公司"},"source_url":"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153983997","content_text":"Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.\nOne of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.\nIf you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.\n\nImage source: Getty Images.\nBioNTech\nI personally don't think a stock market crash is just around the corner. If one is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right, BioNTech (NASDAQ:BNTX) should soar if the market crashes.\nA massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be one of the biggest winners in the group.\nBioNTech and its partner Pfizer (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.\nWhat if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.\nDollar General\nI've maintained for a long time that Dollar General (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.\n\nDG data by YCharts.\nShares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.\nDuring uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.\nEven when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the S&P 500 index did in the five years leading up to 2020 when the market was roaring.\nI think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.\nViatris\nThere are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that Viatris (NASDAQ:VTRS) qualifies on both of these criteria.\nViatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.\nThe stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.\nGranted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157017684,"gmtCreate":1625553395648,"gmtModify":1633939707900,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Wat","listText":"Wat","text":"Wat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/157017684","repostId":"2149033827","repostType":4,"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":801770555,"gmtCreate":1627538886377,"gmtModify":1633763982798,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Help me out😭😭😭. Like and comment&nbsp;","listText":"Help me out😭😭😭. Like and comment&nbsp;","text":"Help me out😭😭😭. Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/801770555","repostId":"2154861924","repostType":4,"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800705614,"gmtCreate":1627316233438,"gmtModify":1633766174533,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool. Please help like my comment","listText":"Cool. Please help like my comment","text":"Cool. Please help like my comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/800705614","repostId":"2154957883","repostType":4,"repost":{"id":"2154957883","kind":"highlight","pubTimestamp":1627298804,"share":"https://www.laohu8.com/m/news/2154957883?lang=&edition=full","pubTime":"2021-07-26 19:26","market":"us","language":"en","title":"3 Warren Buffett Stocks That Are Screaming Summer Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2154957883","media":"Motley Fool","summary":"Riding the Oracle of Omaha's coattails is a moneymaking proposition.","content":"<p>If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than Warren Buffett's track record. As CEO of <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B), Buffett has led his company to an average annual return of 20% since taking the helm in 1965. Through 2020, this worked out to an aggregate return of more than 2,800,000%, and it's created over $500 billion in value for Berkshire Hathaway's shareholders.</p>\n<p>Like all investors, Buffett isn't infallible. He's going to make mistakes from time to time. But he and his investing team have a knack for locating companies with plain-as-day sustainable competitive advantages. As the summer temperatures heat up, the following three Warren Buffett stocks stand out as screaming buys.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e92116e97f06291ec28eda85974acb1b\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Berkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.</span></p>\n<h2>Amazon</h2>\n<p>Was there ever any doubt that <b>Amazon</b> (NASDAQ:AMZN) wouldn't be a screaming buy? Even though it's a stock that was added by Buffett's investing lieutenants (Todd Combs and Ted Weschler) and not the Oracle of Omaha himself, it's nevertheless <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most attractive holdings in Berkshire Hathaway's portfolio.</p>\n<p>As a lot of folks are probably aware, Amazon is the king of the hill when it comes online commerce. This year, the company's marketplace is expected to control roughly $0.40 of every $1 spent online in the United States, according to an April report from eMarketer. The next closest competitor is <b>Walmart</b>, which'll handle about 7% of all U.S. online retail.</p>\n<p>Amazon has been able to pivot its incredible online retail success into signing up more than 200 million people worldwide to a Prime membership. While Prime members enjoy free two-day shipping and access to streaming content, the lure for Amazon is that Prime fees generate tens of billions in added revenue that it can use to undercut brick-and-mortar retailers on price and buoy its margins.</p>\n<p>What you might not realize about Amazon is that it's overwhelmingly dominant in a second industry, as well. Amazon Web Services (AWS) brought in 32% of global cloud infrastructure spending in the first quarter, per Canalys. Cloud infrastructure is still, arguably, in the early innings of its expansion, and it's a considerably higher margin segment for Amazon than retail or advertising. Thus, AWS is going to send Amazon's operating cash flow to the moon as it grows into a larger percentage of total sales.</p>\n<p>For the past 11 years, Wall Street and investors have consistently valued Amazon at a multiple of 23 to 37 times its cash flow. If this range remains intact, a near-tripling in the stock is possible by mid-decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/146ce4600b7c22643629193901a4328a\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Bristol Myers Squibb</h2>\n<p>If value investing suits you better, pharmaceutical stock <b>Bristol Myers Squibb</b> (NYSE:BMY) has the makings of a screaming summer buy.</p>\n<p>The great thing about healthcare stocks is they're highly defensive. Since we don't get to choose when we get sick or what ailments we develop, there's a consistent demand for healthcare services, drugs, and devices, no matter how well or poorly the U.S. and global economy are performing.</p>\n<p>What makes Bristol Myers Squibb such a special company is its organic growth potential and astute dealmaking. To tackle the former, Bristol Myers and <b>Pfizer</b>&nbsp;co-developed the world's leading oral anticoagulant, Eliquis, which looks to be on pace for more than $10 billion in sales this year for Bristol. There's also cancer immunotherapy Opdivo, which is being examined in dozens of ongoing clinical trials. Opdivo is already bringing in about $7 billion annually, and could push higher with continued label expansion opportunities. All told, eight brand-name therapies are on track for at least $1.2 billion in annual sales this year, based on extrapolated Q1 sales totals.</p>\n<p>On the dealmaking front, Bristol Myers Squibb hit a home run when it acquired cancer and immunology drugmaker Celgene in 2019. Celgene's superstar is multiple myeloma drug Revlimid, which brought in $12.1 billion in sales last year and has been growing by a double-digit percentage annually for more than a decade. Longer duration of use, label expansions, improved cancer screening diagnostics, and strong pricing power have all fueled Revlimid's growth. Best of all, it's protected from a large wave of generic competition until the end of January 2026. This means Bristol Myers will be basking in significant cash flow for another 4.5 years.</p>\n<p>In a world where valuation premiums are soaring, it seems unjust that a company so profitable should be valued at only 8.5 times Wall Street's consensus earnings for 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8abdae403dddfa42107e06ea5bfddf39\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>General Motors</h2>\n<p>Lastly, if you want a screaming summer buy that's near and dear to Warren Buffett's investment philosophy, consider auto stock <b>General Motors</b> (NYSE:GM).</p>\n<p>Historically, auto stocks are slow-growing companies that sports high levels of debt and are valued at price-to-earnings multiples that are well below the average S&amp;P 500 company. But General Motors and its peers are the verge of taking advantage of an epic vehicle replacement cycle as consumers and businesses make the shift to electric vehicles (EV).</p>\n<p>Initially, General Motors was going to devote $20 billion to EV investment by mid-decade. However, in November, the company upped its expected outlay to $27 billion by 2025, with the ultimate goal of bringing 30 new EVs to market globally. Some of this capital will be used to bring EVs to market earlier than initially planned, as well as to develop GM's battery technology. With IHS <a href=\"https://laohu8.com/S/MRKT\">Markit</a> forecasting that 10% of all U.S. vehicle sales will be electric by 2025 (up from 1.8% in 2020), a hefty investment in this changing landscape makes sense for GM.</p>\n<p>Equally important are the company's ambitions overseas -- especially in China, the largest auto market in the world. By 2035, the Society of Automotive Engineers of China anticipates that half of all vehicle sales will be some form of alternative energy. Through the first-half of 2021, GM delivered more than 1.5 million vehicles in China.&nbsp; With an established presence, existing infrastructure, and well-known branding, GM has a real shot at becoming an EV leader in China.</p>\n<p>A forward-year price-to-earnings ratio of 8 simply doesn't convey the multi-decade growth opportunity that's on GM's doorstep.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks That Are Screaming Summer Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks That Are Screaming Summer Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-26 19:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车","BMY":"施贵宝","BRK.B":"伯克希尔B","BRK.A":"伯克希尔","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/07/26/3-warren-buffett-stocks-are-screaming-summer-buys/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154957883","content_text":"If you've ever wondered why Wall Street pays such close attention to 90-year-old investor who believes in buying and holding stakes in great businesses for a really long time, look no further than Warren Buffett's track record. As CEO of Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), Buffett has led his company to an average annual return of 20% since taking the helm in 1965. Through 2020, this worked out to an aggregate return of more than 2,800,000%, and it's created over $500 billion in value for Berkshire Hathaway's shareholders.\nLike all investors, Buffett isn't infallible. He's going to make mistakes from time to time. But he and his investing team have a knack for locating companies with plain-as-day sustainable competitive advantages. As the summer temperatures heat up, the following three Warren Buffett stocks stand out as screaming buys.\nBerkshire Hathaway CEO Warren Buffett. Image source: The Motley Fool.\nAmazon\nWas there ever any doubt that Amazon (NASDAQ:AMZN) wouldn't be a screaming buy? Even though it's a stock that was added by Buffett's investing lieutenants (Todd Combs and Ted Weschler) and not the Oracle of Omaha himself, it's nevertheless one of the most attractive holdings in Berkshire Hathaway's portfolio.\nAs a lot of folks are probably aware, Amazon is the king of the hill when it comes online commerce. This year, the company's marketplace is expected to control roughly $0.40 of every $1 spent online in the United States, according to an April report from eMarketer. The next closest competitor is Walmart, which'll handle about 7% of all U.S. online retail.\nAmazon has been able to pivot its incredible online retail success into signing up more than 200 million people worldwide to a Prime membership. While Prime members enjoy free two-day shipping and access to streaming content, the lure for Amazon is that Prime fees generate tens of billions in added revenue that it can use to undercut brick-and-mortar retailers on price and buoy its margins.\nWhat you might not realize about Amazon is that it's overwhelmingly dominant in a second industry, as well. Amazon Web Services (AWS) brought in 32% of global cloud infrastructure spending in the first quarter, per Canalys. Cloud infrastructure is still, arguably, in the early innings of its expansion, and it's a considerably higher margin segment for Amazon than retail or advertising. Thus, AWS is going to send Amazon's operating cash flow to the moon as it grows into a larger percentage of total sales.\nFor the past 11 years, Wall Street and investors have consistently valued Amazon at a multiple of 23 to 37 times its cash flow. If this range remains intact, a near-tripling in the stock is possible by mid-decade.\nImage source: Getty Images.\nBristol Myers Squibb\nIf value investing suits you better, pharmaceutical stock Bristol Myers Squibb (NYSE:BMY) has the makings of a screaming summer buy.\nThe great thing about healthcare stocks is they're highly defensive. Since we don't get to choose when we get sick or what ailments we develop, there's a consistent demand for healthcare services, drugs, and devices, no matter how well or poorly the U.S. and global economy are performing.\nWhat makes Bristol Myers Squibb such a special company is its organic growth potential and astute dealmaking. To tackle the former, Bristol Myers and Pfizer co-developed the world's leading oral anticoagulant, Eliquis, which looks to be on pace for more than $10 billion in sales this year for Bristol. There's also cancer immunotherapy Opdivo, which is being examined in dozens of ongoing clinical trials. Opdivo is already bringing in about $7 billion annually, and could push higher with continued label expansion opportunities. All told, eight brand-name therapies are on track for at least $1.2 billion in annual sales this year, based on extrapolated Q1 sales totals.\nOn the dealmaking front, Bristol Myers Squibb hit a home run when it acquired cancer and immunology drugmaker Celgene in 2019. Celgene's superstar is multiple myeloma drug Revlimid, which brought in $12.1 billion in sales last year and has been growing by a double-digit percentage annually for more than a decade. Longer duration of use, label expansions, improved cancer screening diagnostics, and strong pricing power have all fueled Revlimid's growth. Best of all, it's protected from a large wave of generic competition until the end of January 2026. This means Bristol Myers will be basking in significant cash flow for another 4.5 years.\nIn a world where valuation premiums are soaring, it seems unjust that a company so profitable should be valued at only 8.5 times Wall Street's consensus earnings for 2022.\nImage source: Getty Images.\nGeneral Motors\nLastly, if you want a screaming summer buy that's near and dear to Warren Buffett's investment philosophy, consider auto stock General Motors (NYSE:GM).\nHistorically, auto stocks are slow-growing companies that sports high levels of debt and are valued at price-to-earnings multiples that are well below the average S&P 500 company. But General Motors and its peers are the verge of taking advantage of an epic vehicle replacement cycle as consumers and businesses make the shift to electric vehicles (EV).\nInitially, General Motors was going to devote $20 billion to EV investment by mid-decade. However, in November, the company upped its expected outlay to $27 billion by 2025, with the ultimate goal of bringing 30 new EVs to market globally. Some of this capital will be used to bring EVs to market earlier than initially planned, as well as to develop GM's battery technology. With IHS Markit forecasting that 10% of all U.S. vehicle sales will be electric by 2025 (up from 1.8% in 2020), a hefty investment in this changing landscape makes sense for GM.\nEqually important are the company's ambitions overseas -- especially in China, the largest auto market in the world. By 2035, the Society of Automotive Engineers of China anticipates that half of all vehicle sales will be some form of alternative energy. Through the first-half of 2021, GM delivered more than 1.5 million vehicles in China.  With an established presence, existing infrastructure, and well-known branding, GM has a real shot at becoming an EV leader in China.\nA forward-year price-to-earnings ratio of 8 simply doesn't convey the multi-decade growth opportunity that's on GM's doorstep.","news_type":1},"isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":633903679,"gmtCreate":1643634861324,"gmtModify":1643634861405,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/633903679","repostId":"1178215374","repostType":4,"repost":{"id":"1178215374","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1643634021,"share":"https://www.laohu8.com/m/news/1178215374?lang=&edition=full","pubTime":"2022-01-31 21:00","market":"us","language":"en","title":"Pre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=1178215374","media":"Tiger Newspress","summary":"Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008","content":"<html><head></head><body><p>Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.</p><p><b>Market Snapshot</b></p><p>At 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&amp;P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.</p><p><img src=\"https://static.tigerbbs.com/7d75b4005123cd161b882e9e32b0635e\" tg-width=\"560\" tg-height=\"217\" width=\"100%\" height=\"auto\"/></p><p><b>Pre-Market Movers</b></p><p><a href=\"https://laohu8.com/S/CTXS\">Citrix</a>  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That&#39;s below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a>  (BB) – The communications software company&#39;s stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.</p><p><a href=\"https://laohu8.com/S/SPOT\">Spotify Technology S.A.</a>  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.</p><p><a href=\"https://laohu8.com/S/OTIS\">Otis Worldwide Corp</a>  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a>  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.</p><p><a href=\"https://laohu8.com/S/MPC\">Marathon</a>  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat, Inc.</a> (BYND) – Beyond Meat was double-upgraded to &#34;overweight&#34; from &#34;underweight&#34; at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company&#39;s growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a>  (ISRG) – Intuitive Surgical was upgraded to &#34;overweight&#34; from &#34;neutral&#34; at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.</p><p><a href=\"https://laohu8.com/S/NFLX\">Netflix</a> (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service&#39;s stock to &#34;buy&#34; from &#34;neutral.&#34; Citi said that following the recent sell-off, prevailing equity values don&#39;t reflect material subscriber growth prospects or improving subscriber economics beyond 2023.</p><p><a href=\"https://laohu8.com/S/ALGN\">Align Technology</a>  (ALGN), <a href=\"https://laohu8.com/S/NVST\">Envista Holdings</a>  (NVST) – The maker of Invisalign dental braces was rated &#34;overweight&#34; in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.</p><p><b>Market News</b></p><p>Vodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone&#39;s digital innovation and R&amp;D centre in Malaga, which opened on Monday.</p><p>Norway&#39;s Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.</p><p>Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.</p><p>ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.</p><p>Kalera To Go Public On Nasdaq Through Merger With <a href=\"https://laohu8.com/S/RICOU\">Agrico Acquisition Corp</a>.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.</p><p>Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech&#39;s (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPre-Bell｜Nasdaq Futures Rose on Monday; Netflix, Spotify Upped to Buy at Citigroup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-31 21:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.</p><p><b>Market Snapshot</b></p><p>At 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&amp;P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.</p><p><img src=\"https://static.tigerbbs.com/7d75b4005123cd161b882e9e32b0635e\" tg-width=\"560\" tg-height=\"217\" width=\"100%\" height=\"auto\"/></p><p><b>Pre-Market Movers</b></p><p><a href=\"https://laohu8.com/S/CTXS\">Citrix</a>  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That&#39;s below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BB\">BlackBerry</a>  (BB) – The communications software company&#39;s stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.</p><p><a href=\"https://laohu8.com/S/SPOT\">Spotify Technology S.A.</a>  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.</p><p><a href=\"https://laohu8.com/S/OTIS\">Otis Worldwide Corp</a>  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.</p><p><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a>  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.</p><p><a href=\"https://laohu8.com/S/MPC\">Marathon</a>  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.</p><p><a href=\"https://laohu8.com/S/BYND\">Beyond Meat, Inc.</a> (BYND) – Beyond Meat was double-upgraded to &#34;overweight&#34; from &#34;underweight&#34; at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company&#39;s growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.</p><p><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a>  (ISRG) – Intuitive Surgical was upgraded to &#34;overweight&#34; from &#34;neutral&#34; at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.</p><p><a href=\"https://laohu8.com/S/NFLX\">Netflix</a> (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service&#39;s stock to &#34;buy&#34; from &#34;neutral.&#34; Citi said that following the recent sell-off, prevailing equity values don&#39;t reflect material subscriber growth prospects or improving subscriber economics beyond 2023.</p><p><a href=\"https://laohu8.com/S/ALGN\">Align Technology</a>  (ALGN), <a href=\"https://laohu8.com/S/NVST\">Envista Holdings</a>  (NVST) – The maker of Invisalign dental braces was rated &#34;overweight&#34; in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.</p><p><b>Market News</b></p><p>Vodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone&#39;s digital innovation and R&amp;D centre in Malaga, which opened on Monday.</p><p>Norway&#39;s Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.</p><p>Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.</p><p>ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.</p><p>Kalera To Go Public On Nasdaq Through Merger With <a href=\"https://laohu8.com/S/RICOU\">Agrico Acquisition Corp</a>.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.</p><p>Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech&#39;s (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178215374","content_text":"Nasdaq 100 futures rose on Monday, with the tech-heavy index on track for the worst month since 2008 as investors shied away from stocks with lofty valuations amid aggressive rate hike expectations, mixed earnings and geopolitical tensions.Market SnapshotAt 8 a.m. ET, Dow e-minis were down 192 points, or 0.55%, S&P 500 e-minis were down 16.5 points, or 0.37%, and Nasdaq 100 e-minis were up 9 points, or 0.06%.Pre-Market MoversCitrix  (CTXS) – Citrix is near a deal to be taken private for roughly $13 billion, according to multiple media reports. The deal would see the cloud computing company acquired by Vista Equity Partners and an affiliate of Elliott Management for $104 per share. That's below the Friday closing price for Citrix of $105.55 a share, with the stock up over the past few months on reports of takeover talks. Its shares fell 3.4% in premarket trading.BlackBerry  (BB) – The communications software company's stock tumbled 6.1% in the premarket after it announced a deal to sell its non-core patent assets for $600 million. The patents primarily involve mobile devices, messaging and wireless networking, with patents essential to its current core business not involved in the deal. The buyer is Catapult IP innovations, a special purpose vehicle formed specifically to buy those patents.Spotify Technology S.A.  (SPOT) – Spotify shares rose 1.5% in premarket trading after the audio streaming service took steps to address the controversy surrounding its Joe Rogan podcast, which has been accused of spreading Covid-19 misinformation. Spotify publicized its platform policies and announced the creation of a coronavirus information hub.Otis Worldwide Corp  (OTIS) – The elevator and escalator maker reported quarterly profit of 72 cents per share, 4 cents a share above estimates. Revenue essentially came in line with forecasts. Otis also said sales growth would slow this year and forecast adjusted 2022 earnings per share at $3.20 to $3.30, compared to a consensus estimate of $3.29 a share.Walgreens Boots Alliance  (WBA) – Walgreens has kicked off the sales process for its Boots international drug store unit, according to people with knowledge of the matter who spoke to Bloomberg. A number of buyout firms, including Sycamore Partners, are said to be mulling bids for the unit. Walgreens fell 1% in premarket action.Marathon  (MPC) – Marathon Petroleum is down in premarket trading, following a Reuters report that the United Steelworkers Union rejected a contract offer from the energy producer. The offer would have given refinery and chemical plant workers a 4% pay increase over three years, according to people familiar with the matter. Marathon fell 1.1% in premarket trading.Beyond Meat, Inc. (BYND) – Beyond Meat was double-upgraded to \"overweight\" from \"underweight\" at Barclays, which increased its price target on the maker of plant-based meat alternatives to $80 per share from $70 a share. Barclays cites the company's growth potential, especially in the U.S. retail market. Beyond Meat jumped 4.4% in the premarket.Intuitive Surgical  (ISRG) – Intuitive Surgical was upgraded to \"overweight\" from \"neutral\" at Piper Sandler, which cites a number of factors including valuation for the maker of surgical equipment. The stock had fallen nearly 8% on Jan. 21 following its quarterly earnings and remains at roughly the same level. Intuitive Surgical added 1.2% in premarket action.Netflix (NFLX) – Netflix added 2.5% in the premarket after Citi upgraded the stream service's stock to \"buy\" from \"neutral.\" Citi said that following the recent sell-off, prevailing equity values don't reflect material subscriber growth prospects or improving subscriber economics beyond 2023.Align Technology  (ALGN), Envista Holdings  (NVST) – The maker of Invisalign dental braces was rated \"overweight\" in new coverage at Morgan Stanley, which notes the recovery for the dental market following pandemic-related disruption and said that dental product specialists like Align, Envista, and Dentsply Sirona (XRAY) are poised to benefit. Align and Envista both gained 1.4% in the premarket, while Dentsply was little changed.Market NewsVodafone said on Monday it would work with Intel Corp and other silicon vendors on designing its own chip architecture to drive innovation and efficiency in nascent OpenRAN network technology.The initiative will be based at Vodafone's digital innovation and R&D centre in Malaga, which opened on Monday.Norway's Hammerfest LNG plant faces a further delay before restarting production following a fire in 2020, Equinor    and Norwegian gas system manager Gassco said on Monday.The plant, operated by Equinor, is now expected to resume output on May 17, more than six weeks later than the previous goal of restarting on March 31.Oil major Shell said it would begin trading with a single line of shares on Monday, confirming the assimilation of its A and B shares over the weekend as part of plans to simplify its dual share structure.ABB said on Monday it had increased its majority stake in Chinese electric vehicle (EV) charging provider Chargedot to 80per cent from 67per cent.Kalera To Go Public On Nasdaq Through Merger With Agrico Acquisition Corp.All-Stock Transaction Puts Equity Value Of Combined Co At About $375 Million On A Fully Diluted Pro Forma Basis.Qatari Ministry of Health approved the Pfizer (NYSE:PFE) - BioNTech's (NASDAQ:BNTX) coronavirus vaccine for children aged 5 to 11 years, source Reuters.","news_type":1},"isVote":1,"tweetType":1,"viewCount":902,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":803928733,"gmtCreate":1627402537822,"gmtModify":1633765325132,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Waiting","listText":"Waiting","text":"Waiting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/803928733","repostId":"1108849761","repostType":4,"isVote":1,"tweetType":1,"viewCount":399,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801379154,"gmtCreate":1627485051478,"gmtModify":1633764527605,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Help like pls","listText":"Help like pls","text":"Help like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801379154","repostId":"1179923360","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":177278533,"gmtCreate":1627229964922,"gmtModify":1633767017705,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/177278533","repostId":"2153878189","repostType":4,"isVote":1,"tweetType":1,"viewCount":339,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174914269,"gmtCreate":1627057543351,"gmtModify":1633768342254,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"👍😀","listText":"👍😀","text":"👍😀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/174914269","repostId":"2153983997","repostType":4,"repost":{"id":"2153983997","kind":"highlight","pubTimestamp":1627045860,"share":"https://www.laohu8.com/m/news/2153983997?lang=&edition=full","pubTime":"2021-07-23 21:11","market":"us","language":"en","title":"3 Stocks to Buy Whether or Not a Market Crash Is Near","url":"https://stock-news.laohu8.com/highlight/detail?id=2153983997","media":"Motley Fool","summary":"Maybe the market is about to crash, and maybe it isn't. These stocks look like good picks either way.","content":"<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.</p>\n<p>One of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.</p>\n<p>If you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.</p>\n<p><img src=\"https://static.tigerbbs.com/3105d12ec8b203883b5e91a709172e8b\" tg-width=\"700\" tg-height=\"514\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>BioNTech</h3>\n<p>I personally don't think a stock market crash is just around the corner. If <a href=\"https://laohu8.com/S/AONE.U\">one</a> is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right,&nbsp;<b>BioNTech</b> (NASDAQ:BNTX) should soar if the market crashes.</p>\n<p>A massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest winners in the group.</p>\n<p>BioNTech and its partner <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.</p>\n<p>What if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.</p>\n<h3><a href=\"https://laohu8.com/S/DG\">Dollar General</a></h3>\n<p>I've maintained for a long time that&nbsp;<b>Dollar <a href=\"https://laohu8.com/S/BGC\">General</a></b> (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.</p>\n<p><img src=\"https://static.tigerbbs.com/b0e75aa27d2d22b4296c80687da5be97\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"></p>\n<p>DG data by YCharts.</p>\n<p>Shares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.</p>\n<p>During uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.</p>\n<p>Even when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the <b>S&amp;P 500</b> index did in the five years leading up to 2020 when the market was roaring.</p>\n<p>I think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.</p>\n<h3>Viatris</h3>\n<p>There are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that&nbsp;<b>Viatris</b> (NASDAQ:VTRS) qualifies on both of these criteria.</p>\n<p>Viatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.</p>\n<p>The stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.</p>\n<p>Granted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy Whether or Not a Market Crash Is Near</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy Whether or Not a Market Crash Is Near\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","VTRS":"Viatris Inc.","DG":"美国达乐公司"},"source_url":"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153983997","content_text":"Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.\nOne of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.\nIf you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.\n\nImage source: Getty Images.\nBioNTech\nI personally don't think a stock market crash is just around the corner. If one is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right, BioNTech (NASDAQ:BNTX) should soar if the market crashes.\nA massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be one of the biggest winners in the group.\nBioNTech and its partner Pfizer (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.\nWhat if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.\nDollar General\nI've maintained for a long time that Dollar General (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.\n\nDG data by YCharts.\nShares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.\nDuring uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.\nEven when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the S&P 500 index did in the five years leading up to 2020 when the market was roaring.\nI think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.\nViatris\nThere are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that Viatris (NASDAQ:VTRS) qualifies on both of these criteria.\nViatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.\nThe stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.\nGranted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157017684,"gmtCreate":1625553395648,"gmtModify":1633939707900,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Wat","listText":"Wat","text":"Wat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/157017684","repostId":"2149033827","repostType":4,"repost":{"id":"2149033827","kind":"highlight","pubTimestamp":1625542083,"share":"https://www.laohu8.com/m/news/2149033827?lang=&edition=full","pubTime":"2021-07-06 11:28","market":"us","language":"en","title":"3 Top Stocks That'll Make You Richer in the Second Half of 2021 (and Beyond)","url":"https://stock-news.laohu8.com/highlight/detail?id=2149033827","media":"Motley Fool","summary":"This mix of growth and value stocks can make investors a boatload of money.","content":"<p>If there's one lesson the stock market is always willing to teach, it's that patience pays off. Despite navigating its way through the Black Monday crash in 1987, the dot-com bubble, the Great Recession, and the coronavirus crash, the benchmark <b>S&amp;P 500</b> has delivered an average annual total return of more than 11% since the beginning of 1980.</p>\n<p>Patience can pay off for you, as well, if you put your money to work in game-changing businesses and allow your investment thesis to play out over time. As we move into the second-half of 2021, the following trio of top stocks has the potential to make you a lot richer.<img src=\"https://static.tigerbbs.com/eb8db31ebee93b248d65ac685c65dbac\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2><a href=\"https://laohu8.com/S/CRM\">Salesforce</a></h2>\n<p>If growth stocks tickle your fancy, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the best investments you can make right now for the second half of 2021, and well beyond, is cloud-based customer relationship management (CRM) software provider <b>salesforce.com</b> (NYSE:CRM).</p>\n<p>CRM software is used by consumer-facing businesses to optimize interactions and sales. It helps with real-time information logging, overseeing service and product issues, managing online marketing campaigns, and can offer predictive analysis of what existing clients might buy a new product or service. It's a sustainable double-digit growth opportunity that's been a no-brainer tool used by service-oriented industries, but is becoming more widely used by healthcare, financial, and industrial companies.</p>\n<p>Salesforce is the king of the mountain when it comes to cloud-based CRM. According to estimates from IDC, salesforce nearly controlled 20% of global CRM revenue share in the first-half of 2020. That nearly quadruples its next-closest competitor, and it <i>is</i> more than the four closest competitors, combined.</p>\n<p>In addition to growing its business organically, salesforce has a rich history of making smart acquisitions. Some of its most successful include purchasing Tableau Software in 2019, and MuleSoft in 2018. The latter is responsible for powering the Salesforce Integration Cloud, while the former is a data treasure trove that helps businesses gain a deeper understanding of their customers.</p>\n<p>The newest deal, tallying $27.7 billion, is for cloud-based enterprise communications platform <b><a href=\"https://laohu8.com/S/WORK\">Slack Technologies</a></b>. This deal will allow the company to cross-sell its suite of CRM support solutions to Slack's bevy of small-and-medium-sized businesses.</p>\n<p>This combination of market share dominance, organic growth, and acquisitions has salesforce growing at 20% or more annually. Per CEO Marc Benioff, salesforce is on track to hit a goal of $50 billion in annual sales by fiscal 2026 (up from $21.3 billion in fiscal 2021). This is growth and dominance investors can trust.</p>\n<p><img src=\"https://static.tigerbbs.com/37d129c37c1dfcde03e04fddc2f9a834\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>SSR Mining</h2>\n<p>Don't worry, value investors, I haven't forgotten about you. A second top stock that can make you a lot richer in the latter half of 2021 (and beyond) is precious-metal miner <b>SSR Mining</b> (NASDAQ:SSRM).</p>\n<p>Roughly 10 years ago, gold and silver were soaring and precious-metal miners were liberally spending on new projects, existing mine expansions, and acquisitions. After the price of gold peaked, many were left with less-than-stellar balance sheets. That's not been the case with SSR Mining.</p>\n<p>Last year, SSR completed a merger of equals with Turkey's Alacer Gold. This effectively combined SSR's Marigold and Seabee gold mines, and its silver-producing Puna operations in Argentina, with Alacer's Copler gold mine. Altogether, these four producing assets should yield between 700,000 gold equivalent ounces (GEO) and 800,000 GEO annually for the next five years, if not longer. Prior to the deal, SSR was producing a little north of 400,000 GEO annually.</p>\n<p>Here's the thing: Whereas most gold stocks have scrambled to pay down debt, SSR is sitting on a net cash balance of around $400 million, as of the end of March 2021. The roughly $450 million the company is expecting to generate in annual free cash flow has allowed it to begin paying a $0.05 quarterly dividend, as well as institute a $150 million share buyback program.</p>\n<p>In addition to improved output, a dividend, and a share buyback program, SSR Mining should benefit from stronger precious-metal prices. The Federal Reserve continues to hold off on raising historically low lending rates, while the prospect for longer-term inflation is climbing. Both scenarios point to investors continuing to flock to gold as a potential store of value.</p>\n<p>Just how cheap is SSR Mining? Shares can currently be purchased for less than 9 times Wall Street's forward-year earnings estimate. Even more telling, SSR is valued at a multiple of 5 times this year's estimated cash flow, which implies a significant discount to a fair valuation, which I'd peg as closer to 10 times cash flow.</p>\n<p><img src=\"https://static.tigerbbs.com/de67cc325c8403c33a12cc0935dcf46f\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>Trulieve Cannabis</h2>\n<p>A third company that can make investors richer in the second half of 2021 is marijuana stock <b>Trulieve Cannabis</b> (OTC:TCNNF).</p>\n<p>There's no question that cannabis is a sustainable double-digit growth opportunity. But considering the regulatory issues and atrocious balance sheets that accompany most Canadian pot stocks, the U.S. is the smart way to play the cannabis craze. By mid-decade, the U.S. could be bringing in more than $41 billion in annual weed sales, per <a href=\"https://laohu8.com/S/NFC.U\">New Frontier</a> Data.</p>\n<p>What makes multistate operator (MSO) Trulieve so special is how the company has chosen to expand. Many large MSOs have opened retail, cultivation, and processing facilities in as many legalized states as reasonable. As for Trulieve, it has 91 operational retail locations in the U.S., 85 of which are located in medical marijuana-legal Florida. That's right -- it's opened 85 dispensaries in a single state.</p>\n<p>How's that worked out? By blanketing the Sunshine State, Trulieve Cannabis has been able to gobble up 53% of Florida's dried cannabis market share and 49% of its higher-margin cannabinoid oils share. In other words, the company has effectively built up its brand and a loyal customer following without having to break the bank with its marketing budget. As a result, it recently reported its 13th consecutive profitable quarter.</p>\n<p>In May, we learned that the next chapter for Trulieve will entail taking its blueprint to new markets. On May 10, it announced a $2.1 billion deal to acquire MSO <b>Harvest Health &amp; Recreation</b> (OTC:HRVSF). Harvest Health has a five-state focus, one of which includes Florida. Thus, Trulieve will soon have an even larger presence in the Sunshine State. But the big driver of this deal is Harvest's 15 operational dispensaries in Arizona, which legalized adult-use cannabis in November and began sales in January. Nothing would stop Trulieve from becoming a dominant force in Arizona's potential billion-dollar weed market.</p>\n<p>With its rich history of profitability and stunning growth potential, Trulieve Cannabis checks all the right boxes to be a moneymaker for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Stocks That'll Make You Richer in the Second Half of 2021 (and Beyond)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Stocks That'll Make You Richer in the Second Half of 2021 (and Beyond)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 11:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/05/3-top-stocks-make-you-richer-second-half-of-2021/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If there's one lesson the stock market is always willing to teach, it's that patience pays off. Despite navigating its way through the Black Monday crash in 1987, the dot-com bubble, the Great ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/05/3-top-stocks-make-you-richer-second-half-of-2021/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCNNF":"Trulieve Cannabis Corporation","SSRM":"SSR Mining Inc","CRM":"赛富时"},"source_url":"https://www.fool.com/investing/2021/07/05/3-top-stocks-make-you-richer-second-half-of-2021/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149033827","content_text":"If there's one lesson the stock market is always willing to teach, it's that patience pays off. Despite navigating its way through the Black Monday crash in 1987, the dot-com bubble, the Great Recession, and the coronavirus crash, the benchmark S&P 500 has delivered an average annual total return of more than 11% since the beginning of 1980.\nPatience can pay off for you, as well, if you put your money to work in game-changing businesses and allow your investment thesis to play out over time. As we move into the second-half of 2021, the following trio of top stocks has the potential to make you a lot richer.\nImage source: Getty Images.\nSalesforce\nIf growth stocks tickle your fancy, one of the best investments you can make right now for the second half of 2021, and well beyond, is cloud-based customer relationship management (CRM) software provider salesforce.com (NYSE:CRM).\nCRM software is used by consumer-facing businesses to optimize interactions and sales. It helps with real-time information logging, overseeing service and product issues, managing online marketing campaigns, and can offer predictive analysis of what existing clients might buy a new product or service. It's a sustainable double-digit growth opportunity that's been a no-brainer tool used by service-oriented industries, but is becoming more widely used by healthcare, financial, and industrial companies.\nSalesforce is the king of the mountain when it comes to cloud-based CRM. According to estimates from IDC, salesforce nearly controlled 20% of global CRM revenue share in the first-half of 2020. That nearly quadruples its next-closest competitor, and it is more than the four closest competitors, combined.\nIn addition to growing its business organically, salesforce has a rich history of making smart acquisitions. Some of its most successful include purchasing Tableau Software in 2019, and MuleSoft in 2018. The latter is responsible for powering the Salesforce Integration Cloud, while the former is a data treasure trove that helps businesses gain a deeper understanding of their customers.\nThe newest deal, tallying $27.7 billion, is for cloud-based enterprise communications platform Slack Technologies. This deal will allow the company to cross-sell its suite of CRM support solutions to Slack's bevy of small-and-medium-sized businesses.\nThis combination of market share dominance, organic growth, and acquisitions has salesforce growing at 20% or more annually. Per CEO Marc Benioff, salesforce is on track to hit a goal of $50 billion in annual sales by fiscal 2026 (up from $21.3 billion in fiscal 2021). This is growth and dominance investors can trust.\n\nImage source: Getty Images.\nSSR Mining\nDon't worry, value investors, I haven't forgotten about you. A second top stock that can make you a lot richer in the latter half of 2021 (and beyond) is precious-metal miner SSR Mining (NASDAQ:SSRM).\nRoughly 10 years ago, gold and silver were soaring and precious-metal miners were liberally spending on new projects, existing mine expansions, and acquisitions. After the price of gold peaked, many were left with less-than-stellar balance sheets. That's not been the case with SSR Mining.\nLast year, SSR completed a merger of equals with Turkey's Alacer Gold. This effectively combined SSR's Marigold and Seabee gold mines, and its silver-producing Puna operations in Argentina, with Alacer's Copler gold mine. Altogether, these four producing assets should yield between 700,000 gold equivalent ounces (GEO) and 800,000 GEO annually for the next five years, if not longer. Prior to the deal, SSR was producing a little north of 400,000 GEO annually.\nHere's the thing: Whereas most gold stocks have scrambled to pay down debt, SSR is sitting on a net cash balance of around $400 million, as of the end of March 2021. The roughly $450 million the company is expecting to generate in annual free cash flow has allowed it to begin paying a $0.05 quarterly dividend, as well as institute a $150 million share buyback program.\nIn addition to improved output, a dividend, and a share buyback program, SSR Mining should benefit from stronger precious-metal prices. The Federal Reserve continues to hold off on raising historically low lending rates, while the prospect for longer-term inflation is climbing. Both scenarios point to investors continuing to flock to gold as a potential store of value.\nJust how cheap is SSR Mining? Shares can currently be purchased for less than 9 times Wall Street's forward-year earnings estimate. Even more telling, SSR is valued at a multiple of 5 times this year's estimated cash flow, which implies a significant discount to a fair valuation, which I'd peg as closer to 10 times cash flow.\n\nImage source: Getty Images.\nTrulieve Cannabis\nA third company that can make investors richer in the second half of 2021 is marijuana stock Trulieve Cannabis (OTC:TCNNF).\nThere's no question that cannabis is a sustainable double-digit growth opportunity. But considering the regulatory issues and atrocious balance sheets that accompany most Canadian pot stocks, the U.S. is the smart way to play the cannabis craze. By mid-decade, the U.S. could be bringing in more than $41 billion in annual weed sales, per New Frontier Data.\nWhat makes multistate operator (MSO) Trulieve so special is how the company has chosen to expand. Many large MSOs have opened retail, cultivation, and processing facilities in as many legalized states as reasonable. As for Trulieve, it has 91 operational retail locations in the U.S., 85 of which are located in medical marijuana-legal Florida. That's right -- it's opened 85 dispensaries in a single state.\nHow's that worked out? By blanketing the Sunshine State, Trulieve Cannabis has been able to gobble up 53% of Florida's dried cannabis market share and 49% of its higher-margin cannabinoid oils share. In other words, the company has effectively built up its brand and a loyal customer following without having to break the bank with its marketing budget. As a result, it recently reported its 13th consecutive profitable quarter.\nIn May, we learned that the next chapter for Trulieve will entail taking its blueprint to new markets. On May 10, it announced a $2.1 billion deal to acquire MSO Harvest Health & Recreation (OTC:HRVSF). Harvest Health has a five-state focus, one of which includes Florida. Thus, Trulieve will soon have an even larger presence in the Sunshine State. But the big driver of this deal is Harvest's 15 operational dispensaries in Arizona, which legalized adult-use cannabis in November and began sales in January. Nothing would stop Trulieve from becoming a dominant force in Arizona's potential billion-dollar weed market.\nWith its rich history of profitability and stunning growth potential, Trulieve Cannabis checks all the right boxes to be a moneymaker for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800704067,"gmtCreate":1627316261959,"gmtModify":1633766174288,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/800704067","repostId":"1191215576","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174917552,"gmtCreate":1627057631176,"gmtModify":1633768341929,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174917552","repostId":"2153751984","repostType":4,"repost":{"id":"2153751984","kind":"highlight","pubTimestamp":1627050780,"share":"https://www.laohu8.com/m/news/2153751984?lang=&edition=full","pubTime":"2021-07-23 22:33","market":"us","language":"en","title":"Got $1,000? Buy These Cheap Growth Stocks Right Away","url":"https://stock-news.laohu8.com/highlight/detail?id=2153751984","media":"Motley Fool","summary":"These growth stocks have made investors rich in the past, and they can keep doing so in the future.","content":"<p>It is difficult to find high-growth companies trading at attractive valuations, especially in the technology sector, where stocks usually trade at rich valuations. The rich valuations happen because they tend to outperform the broader market on the back of disruptive products and services that may fuel rapid long-term growth.</p>\n<p>Not surprisingly, the average price-to-earnings (P/E) ratio of the tech-heavy&nbsp;<b><a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 100</b> Index stands&nbsp;at 38.4 as compared to the <b>Dow Jones Industrial Average</b>'s average P/E ratio of 26.3 and the <b>S&amp;P 500</b>'s average multiple of 36.6.</p>\n<p>However, there are a few tech companies that continue to trade at attractive valuations despite crushing the broader market. <b><a href=\"https://laohu8.com/S/QRVO\">Qorvo</a></b> (NASDAQ:QRVO) and <b>Jabil</b> (NYSE:JBL) are two stocks that have made investors significantly richer over the past five years.</p>\n<p><img src=\"https://static.tigerbbs.com/549aaadbeda352ae2081da23ac1deb45\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"></p>\n<p>QRVO data by YCharts</p>\n<p>For example, a $1,000 investment in Qorvo five years ago would be worth almost $3,100 now. A similar investment in Jabil would be worth close to $2,700 now. The good part is that both companies could at least equal, if not outperform, their stellar gains in the coming years. Let's take a look at the reasons why it still makes sense to invest $1,000 in these tech stocks.</p>\n<h3>Qorvo: Riding the 5G wave</h3>\n<p>Qorvo is benefiting from multiple hot tech trends right now, but its biggest catalyst remains the 5G smartphone market. The chipmaker's revenue in fiscal 2021 (which ended on April 3) shot up 24% year over year to $4.02 billion. It finished the year with a gross profit margin of 46.9%, up substantially over the prior year's figure of 40.8%.</p>\n<p>Qorvo credited the \"higher demand for our 5G mobile solutions, 5G base station products, and Wi-Fi products\" for this impressive showing. The good news is that all these verticals are still in their early phases of growth. For instance, 5G smartphone shipments are expected to jump from an estimated 239 million units in 2020 to 1.12 billion units by 2025, according&nbsp;to Taiwan-based Market Intelligence &amp; Consulting Institute.</p>\n<p><img src=\"https://static.tigerbbs.com/4f9ffe2f3eb673512439f8114e7d18f2\" tg-width=\"700\" tg-height=\"510\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<p>With Qorvo getting just over 71% of its total&nbsp;revenue from the mobile products segment last quarter, the 5G smartphone boom is going to move the needle significantly for the company. After all, the chipmaker supplies its wireless components to the leading players in the 5G smartphone space, including <b><a href=\"https://laohu8.com/S/AAPL\">Apple</a></b> (NASDAQ:AAPL). The iPhone maker produced 30%&nbsp;of Qorvo's total revenue last fiscal year.</p>\n<p>This sizable reliance on Apple is a good thing for Qorvo as the tech giant is on fire in the 5G smartphone era. The iPhone 12 has been a runaway hit among consumers looking to make the move to a 5G device from their older iPhones, and there are at least 800 million customers in Apple's installed base that have yet to make the move to 5G. As a result, Apple is going to be a long-term catalyst for Qorvo's mobile business thanks to the massive iPhone volume opportunity at hand.</p>\n<p>Its relationship with other smartphone OEMs (original equipment manufacturers) such&nbsp;as <b>Samsung</b> and <b>Xiaomi</b> will also come in handy in the long run, as these companies are dominant&nbsp;players in the 5G smartphone market along with Apple.</p>\n<p>More importantly, the improved 5G smartphone volumes will help Qorvo generate faster revenue and earnings growth. That's because the radio-frequency (RF) content in mid-range 5G smartphones is doubling over their 4G predecessors, while high-end devices are witnessing an additional $5 to $7 in wireless content.</p>\n<p>Thanks to the 5G tailwind, Qorvo is anticipated to record 16% annual earnings growth for the next five years, up from the 6% annual growth seen in the last five years. This makes it an attractive growth stock to buy right now at 29.7 times trailing earnings, which is lower than the Nasdaq 100 Index's rich multiple we saw earlier.</p>\n<h3>Jabil: Diverse growth drivers should lead to better times</h3>\n<p>Jabil has made a fine comeback this year after the novel coronavirus pandemic derailed the company's growth in 2020. The contract electronics manufacturer delivered a solid third-quarter earnings report&nbsp;in June, recording 14% year-over-year revenue growth to $7.2 billion. Non-GAAP earnings had shot up to $1.30 per share during the quarter from $0.37 per share a year ago. <b>&nbsp;</b></p>\n<p>Even better, Jabil upgraded its full-year guidance on the back of impressive momentum in the cloud, mobility, semiconductor, automotive, and connected devices markets. These end markets are on track to grow nicely for Jabil this year and beyond.</p>\n<p>In mobility, for instance, Jabil expects $4.1 billion in revenue this fiscal year, up 24% over fiscal 2020. That's not surprising as 20%&nbsp;of the company's total revenue comes from manufacturing casings for Apple's iPhone and iPad. We have already seen that Apple's 5G iPhones are selling like hotcakes, and they can keep doing so thanks to an upgrade supercycle that's currently playing out. This should rub off positively on Jabil's prospects as well since it has a close relationship with Apple.</p>\n<p>However, Jabil draws its revenue from a wider number of verticals. The automotive and transportation segment, for example, is expected&nbsp;to deliver $2.2 billion in revenue this year, up 29% from last year. This business seems to have solid long-term potential as the global automotive contract manufacturing space is expected to clock 7.2% annual growth through 2027, according&nbsp;to a third-party estimate.</p>\n<p>Similarly, Jabil provides contract manufacturing services to connected device manufacturers, semiconductor capital equipment makers, cloud computing customers, and networking and storage providers, among others. Grand View Research estimates&nbsp;that the global contract electronics manufacturing market could be worth $800 billion by 2027 as compared to $417 billion at the end of 2019.</p>\n<p>Not surprisingly, Jabil's bottom line is expected to grow at nearly 20% per year for the next five years, as it seems to be on track to take advantage of the huge end-market opportunity that lies ahead. And now would be a great time to buy this tech stock as it is trading at just 14 times trailing earnings, which makes it way cheaper&nbsp;than the indexes discussed earlier. What's more, Jabil's forward earnings multiple of just 9.3 makes it even more attractive, giving investors another great reason to consider putting $1,000 in the stock.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? Buy These Cheap Growth Stocks Right Away</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? Buy These Cheap Growth Stocks Right Away\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 22:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/got-1000-buy-these-cheap-growth-stocks-right-away/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It is difficult to find high-growth companies trading at attractive valuations, especially in the technology sector, where stocks usually trade at rich valuations. The rich valuations happen because ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/got-1000-buy-these-cheap-growth-stocks-right-away/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","QRVO":"Qorvo, Inc.","03086":"华夏纳指","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/07/23/got-1000-buy-these-cheap-growth-stocks-right-away/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153751984","content_text":"It is difficult to find high-growth companies trading at attractive valuations, especially in the technology sector, where stocks usually trade at rich valuations. The rich valuations happen because they tend to outperform the broader market on the back of disruptive products and services that may fuel rapid long-term growth.\nNot surprisingly, the average price-to-earnings (P/E) ratio of the tech-heavy Nasdaq 100 Index stands at 38.4 as compared to the Dow Jones Industrial Average's average P/E ratio of 26.3 and the S&P 500's average multiple of 36.6.\nHowever, there are a few tech companies that continue to trade at attractive valuations despite crushing the broader market. Qorvo (NASDAQ:QRVO) and Jabil (NYSE:JBL) are two stocks that have made investors significantly richer over the past five years.\n\nQRVO data by YCharts\nFor example, a $1,000 investment in Qorvo five years ago would be worth almost $3,100 now. A similar investment in Jabil would be worth close to $2,700 now. The good part is that both companies could at least equal, if not outperform, their stellar gains in the coming years. Let's take a look at the reasons why it still makes sense to invest $1,000 in these tech stocks.\nQorvo: Riding the 5G wave\nQorvo is benefiting from multiple hot tech trends right now, but its biggest catalyst remains the 5G smartphone market. The chipmaker's revenue in fiscal 2021 (which ended on April 3) shot up 24% year over year to $4.02 billion. It finished the year with a gross profit margin of 46.9%, up substantially over the prior year's figure of 40.8%.\nQorvo credited the \"higher demand for our 5G mobile solutions, 5G base station products, and Wi-Fi products\" for this impressive showing. The good news is that all these verticals are still in their early phases of growth. For instance, 5G smartphone shipments are expected to jump from an estimated 239 million units in 2020 to 1.12 billion units by 2025, according to Taiwan-based Market Intelligence & Consulting Institute.\n\nImage source: Getty Images.\nWith Qorvo getting just over 71% of its total revenue from the mobile products segment last quarter, the 5G smartphone boom is going to move the needle significantly for the company. After all, the chipmaker supplies its wireless components to the leading players in the 5G smartphone space, including Apple (NASDAQ:AAPL). The iPhone maker produced 30% of Qorvo's total revenue last fiscal year.\nThis sizable reliance on Apple is a good thing for Qorvo as the tech giant is on fire in the 5G smartphone era. The iPhone 12 has been a runaway hit among consumers looking to make the move to a 5G device from their older iPhones, and there are at least 800 million customers in Apple's installed base that have yet to make the move to 5G. As a result, Apple is going to be a long-term catalyst for Qorvo's mobile business thanks to the massive iPhone volume opportunity at hand.\nIts relationship with other smartphone OEMs (original equipment manufacturers) such as Samsung and Xiaomi will also come in handy in the long run, as these companies are dominant players in the 5G smartphone market along with Apple.\nMore importantly, the improved 5G smartphone volumes will help Qorvo generate faster revenue and earnings growth. That's because the radio-frequency (RF) content in mid-range 5G smartphones is doubling over their 4G predecessors, while high-end devices are witnessing an additional $5 to $7 in wireless content.\nThanks to the 5G tailwind, Qorvo is anticipated to record 16% annual earnings growth for the next five years, up from the 6% annual growth seen in the last five years. This makes it an attractive growth stock to buy right now at 29.7 times trailing earnings, which is lower than the Nasdaq 100 Index's rich multiple we saw earlier.\nJabil: Diverse growth drivers should lead to better times\nJabil has made a fine comeback this year after the novel coronavirus pandemic derailed the company's growth in 2020. The contract electronics manufacturer delivered a solid third-quarter earnings report in June, recording 14% year-over-year revenue growth to $7.2 billion. Non-GAAP earnings had shot up to $1.30 per share during the quarter from $0.37 per share a year ago.  \nEven better, Jabil upgraded its full-year guidance on the back of impressive momentum in the cloud, mobility, semiconductor, automotive, and connected devices markets. These end markets are on track to grow nicely for Jabil this year and beyond.\nIn mobility, for instance, Jabil expects $4.1 billion in revenue this fiscal year, up 24% over fiscal 2020. That's not surprising as 20% of the company's total revenue comes from manufacturing casings for Apple's iPhone and iPad. We have already seen that Apple's 5G iPhones are selling like hotcakes, and they can keep doing so thanks to an upgrade supercycle that's currently playing out. This should rub off positively on Jabil's prospects as well since it has a close relationship with Apple.\nHowever, Jabil draws its revenue from a wider number of verticals. The automotive and transportation segment, for example, is expected to deliver $2.2 billion in revenue this year, up 29% from last year. This business seems to have solid long-term potential as the global automotive contract manufacturing space is expected to clock 7.2% annual growth through 2027, according to a third-party estimate.\nSimilarly, Jabil provides contract manufacturing services to connected device manufacturers, semiconductor capital equipment makers, cloud computing customers, and networking and storage providers, among others. Grand View Research estimates that the global contract electronics manufacturing market could be worth $800 billion by 2027 as compared to $417 billion at the end of 2019.\nNot surprisingly, Jabil's bottom line is expected to grow at nearly 20% per year for the next five years, as it seems to be on track to take advantage of the huge end-market opportunity that lies ahead. And now would be a great time to buy this tech stock as it is trading at just 14 times trailing earnings, which makes it way cheaper than the indexes discussed earlier. What's more, Jabil's forward earnings multiple of just 9.3 makes it even more attractive, giving investors another great reason to consider putting $1,000 in the stock.","news_type":1},"isVote":1,"tweetType":1,"viewCount":314,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174915258,"gmtCreate":1627057508774,"gmtModify":1633768343069,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174915258","repostId":"2153983997","repostType":4,"repost":{"id":"2153983997","kind":"highlight","pubTimestamp":1627045860,"share":"https://www.laohu8.com/m/news/2153983997?lang=&edition=full","pubTime":"2021-07-23 21:11","market":"us","language":"en","title":"3 Stocks to Buy Whether or Not a Market Crash Is Near","url":"https://stock-news.laohu8.com/highlight/detail?id=2153983997","media":"Motley Fool","summary":"Maybe the market is about to crash, and maybe it isn't. These stocks look like good picks either way.","content":"<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.</p>\n<p>One of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.</p>\n<p>If you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.</p>\n<p><img src=\"https://static.tigerbbs.com/3105d12ec8b203883b5e91a709172e8b\" tg-width=\"700\" tg-height=\"514\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>BioNTech</h3>\n<p>I personally don't think a stock market crash is just around the corner. If <a href=\"https://laohu8.com/S/AONE.U\">one</a> is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right,&nbsp;<b>BioNTech</b> (NASDAQ:BNTX) should soar if the market crashes.</p>\n<p>A massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest winners in the group.</p>\n<p>BioNTech and its partner <b><a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.</p>\n<p>What if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.</p>\n<h3><a href=\"https://laohu8.com/S/DG\">Dollar General</a></h3>\n<p>I've maintained for a long time that&nbsp;<b>Dollar <a href=\"https://laohu8.com/S/BGC\">General</a></b> (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.</p>\n<p><img src=\"https://static.tigerbbs.com/b0e75aa27d2d22b4296c80687da5be97\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"></p>\n<p>DG data by YCharts.</p>\n<p>Shares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.</p>\n<p>During uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.</p>\n<p>Even when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the <b>S&amp;P 500</b> index did in the five years leading up to 2020 when the market was roaring.</p>\n<p>I think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.</p>\n<h3>Viatris</h3>\n<p>There are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that&nbsp;<b>Viatris</b> (NASDAQ:VTRS) qualifies on both of these criteria.</p>\n<p>Viatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.</p>\n<p>The stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.</p>\n<p>Granted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy Whether or Not a Market Crash Is Near</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy Whether or Not a Market Crash Is Near\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 21:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","VTRS":"Viatris Inc.","DG":"美国达乐公司"},"source_url":"https://www.fool.com/investing/2021/07/23/3-stocks-to-buy-whether-or-not-a-market-crash-is-n/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153983997","content_text":"Rising COVID-19 cases. Concerns about the highly contagious delta variant. The possibility of another housing bubble bursting. These are some of the reasons why worries are increasing among investors that a stock market crash could be on the way.\nOne of the biggest stock market bears, Harry Dent Jr., who predicted the dot.com bubble collapsing, even thinks that a market meltdown is likely within the next three months. Is all of the pessimism warranted? Maybe, maybe not.\nIf you're leery about what's around the corner, here are three stocks to buy if a market crash is coming soon. And the great news about these stocks is that they're solid picks even if it doesn't happen.\n\nImage source: Getty Images.\nBioNTech\nI personally don't think a stock market crash is just around the corner. If one is, though, I suspect the cause will be the combination of the COVID-19 pandemic and sky-high market valuations. Assuming I'm right, BioNTech (NASDAQ:BNTX) should soar if the market crashes.\nA massive market sell-off due to COVID-19 worries would almost certainly light a fire beneath the stocks of the leading vaccine makers. My view is that BioNTech would be one of the biggest winners in the group.\nBioNTech and its partner Pfizer (NYSE:PFE) are already moving forward with plans to test a vaccine that specifically targets the delta variant. That gives the companies a head start. BioNTech is by far the smallest of the companies with COVID-19 vaccines already on the market, which makes its shares more likely to jump higher on a positive catalyst. It's also easily the cheapest of these vaccine stocks, based on forward earnings multiples.\nWhat if there isn't an imminent market crash? BioNTech is still set to rake in billions of dollars with sales of its COVID-19 vaccine. The company will almost certainly use its growing cash stockpile to invest in expanding its pipeline. I think that BioNTech will be a winner over the long term, regardless of what happens over the short term.\nDollar General\nI've maintained for a long time that Dollar General (NYSE:DG) is one of the best stocks to own during a market downturn. That view seemed to be confirmed during the big market meltdown last year.\n\nDG data by YCharts.\nShares of Dollar General fell at first, but not nearly as much as most stocks did. Dollar General stock also rebounded much more quickly and trounced the overall market's return throughout the rest of the year.\nDuring uncertain times, consumers tighten their purse strings. That makes discount retailers such as Dollar General more attractive than ever.\nEven when the overall market performs well, though, Dollar General should still be able to grow. As a case in point, the company's shares delivered more than double the gain that the S&P 500 index did in the five years leading up to 2020 when the market was roaring.\nI think that Dollar General will be able to continue to beat the market. It's moving forward with an aggressive expansion strategy. The company is also undertaking a major initiative to \"establish itself as a health destination.\" While Dollar General didn't provide many details on exactly what its plans are, moving more into healthcare sounds like a smart move to me.\nViatris\nThere are at least two reasons why a given stock might hold up well during a big market sell-off. One is that its underlying business isn't impacted much by the reason behind the broader plunge. Another is that the stock is so cheap that investors scoop up shares if it falls much below its existing price. My take is that Viatris (NASDAQ:VTRS) qualifies on both of these criteria.\nViatris specializes in biosimilars and generic drugs. Patients need these drugs, regardless of what the stock market does. The drugs are also less expensive than branded prescription drugs.\nThe stock is irrefutably dirt cheap. Viatris' shares trade at a little over four times expected earnings. It's unlikely that the stock is going to move much lower because it would simply be too much of a steal for investors to ignore.\nGranted, Viatris probably won't keep up with the overall stock market's performance if the current uptrend continues. However, the company's dividend is attractive. And over the next several years, Viatris should achieve synergies resulting from the merger of Pfizer's Upjohn unit and Mylan, as well as launch new products that should drive growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801379429,"gmtCreate":1627485072361,"gmtModify":1633764527361,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/801379429","repostId":"1102922788","repostType":4,"repost":{"id":"1102922788","kind":"news","pubTimestamp":1627479526,"share":"https://www.laohu8.com/m/news/1102922788?lang=&edition=full","pubTime":"2021-07-28 21:38","market":"us","language":"en","title":"Fed Meeting Will Focus on Tapering Timeline.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102922788","media":"The Wall Street Journal","summary":"Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\n","content":"<p>Officials are looking to forge consensus on how and when to eventually reduce their asset purchases</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b506b5e7aef3659e57731a13007a3078\" tg-width=\"1290\" tg-height=\"859\" width=\"100%\" height=\"auto\"><span>Fed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised ample notice before reducing purchases of securities.</span></p>\n<p>Federal Reserve officials are set to resume deliberations Wednesday about how and when to begin&nbsp;paring their asset purchases&nbsp;amid an economic rebound clouded by supply-chain bottlenecks and rising Covid-19 cases.</p>\n<p>The central bank at the end of last year said it would continue to purchase $120 billion in Treasurys and mortgage-backed securities monthly until officials deemed they had achieved “substantial further progress” toward their goals of low unemployment and inflation reaching their 2% goal.</p>\n<p>The Fed will release its policy statement at 2 p.m. EDT. Most of the focus is likely to center on Chairman Jerome Powell’s news conference at 2:30 p.m. Here’s what to watch:</p>\n<p><b>Taper timing</b></p>\n<p>Officials are likely to receive a formal staff briefing around when to start paring their monthly purchases of $80 billion in Treasury securities and $40 billion in mortgage securities, and how quickly to reduce, or taper, them.</p>\n<p>The Fed began buying large quantities of the securities in March 2020, when the Covid-19 pandemic triggered a near-meltdown in financial markets. With the Fed’s short-term interest rate at zero, the purchases are designed to provide additional stimulus by holding down long-term interest rates.</p>\n<p>Some officials are concerned&nbsp;that a burst of inflation this year from bottlenecks associated with reopening the economy will prove more durable than previously anticipated. These policy makers are eager to start the taper, in part because they and their colleagues have said they aren’t likely to consider raising interest rates from near zero until they are done tapering the asset purchases.</p>\n<p>Another camp thinks recent&nbsp;price pressures will subside&nbsp;and could leave the Fed in the same position that it faced for much of the past decade, in which global forces kept inflation below 2% even with historically low interest rates. They are worried that accelerating plans to wind down the asset purchases could raise questions among investors about the Fed’s commitment to achieving its economic goals.</p>\n<p>Because Mr. Powell has pledged&nbsp;to provide ample notice&nbsp;to financial markets before the Fed starts tapering&nbsp;to avoid catching investors by surprise, the central bank looks unlikely to start the process now or at its next meeting in September. Mr. Powell’s press conference will be heavily scrutinized for clues on how officials judge recent economic progress. In April, he said the Fed was “a long way from” its tapering goals, and he characterized the economy as “still a ways off” from them in June.</p>\n<p><b>Purchase pace</b></p>\n<p>Officials also must consider the pace of any reductions. Some officials have discussed concluding the purchases around October 2022 so they could lift rates soon thereafter if the recovery is stronger or inflation is higher than now anticipated.</p>\n<p>During a prior asset-purchase program that ended in 2014, the Fed shrank its purchases in modest, equal amounts over the course of 10 months. It then waited another 14 months before raising interest rates.</p>\n<p>Another tactical question centers on whether&nbsp;to reduce the pace of Treasurys and mortgage-backed securities equally. Some officials have raised concerns about rising home prices and are pressing to stop purchases of mortgage bonds sooner.</p>\n<p>But Mr. Powell and other officials have poured cold water on those concerns in recent weeks. They have said mortgage buying, by purchasing longer-dated assets, provides a way to more broadly stimulate the economy and isn’t focused squarely on housing markets.</p>\n<p>“If the housing market has you really worried, that’s an argument for just tapering everything sooner and faster,” said William English, a former senior Fed economist who is now a professor at the Yale School of Management.</p>\n<p><b>Inflation outlook</b></p>\n<p>For a third straight month in June,inflation ran hotter&nbsp;than many economists had expected. The Labor Department’s consumer-price index increased 5.4% from a year ago, the highest 12-month rate since August 2008.</p>\n<p>Mr. Powell said two weeks ago that&nbsp;many of the elevated price pressures&nbsp;can still be traced to goods and services affected by supply-chain bottlenecks and other pandemic-driven upheaval. As a result, he said it would be too soon for the Fed to abandon its earlier expectation that prices will return to their 2% target on their own and to raise rates to cool down demand and reduce inflation faster.</p>\n<p>But Mr. Powell could face questions over how long the central bank and its 12-member rate-setting committee feels it would take to revisit their projections. Price pressures in some sectors of the economy where inflation had been subdued over the past year, including residential rents, have picked in recent months.</p>\n<p><b>Delta variant</b></p>\n<p>Mr. Powell is also likely to be pressed on how the recent increase in Covid-19 cases among unvaccinated populations could reshape the central bank’s growth forecasts for the rest of the year. While a return to shutdowns and other state-mandated restrictions on activity seem less likely than a year ago, increased hesitancy on the part of consumers to return to normal spending routines could complicate the economic outlook.</p>\n<p>Since Fed officials last met in June, government-bond prices have jumped, a sign that investors are less confident about long-term growth prospects and less worried about inflation.</p>\n<p>Yields, which rise when bond prices fall, climbed sharply earlier in the year, lifted by expectations that vaccinations and fiscal stimulus would spur an economic boom. After hitting a 13-month high of 1.75% at the end of March, the 10-year Treasury yield has declined—to 1.57% on June 16, after the Fed concluded its previous meeting, and to 1.24%, a five-month low, when the Fed’s meeting began on Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Meeting Will Focus on Tapering Timeline.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Meeting Will Focus on Tapering Timeline.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-28 21:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\nFed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised...</p>\n\n<a href=\"https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/fed-meeting-will-focus-on-tapering-timeline-11627464602?mod=hp_lead_pos2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102922788","content_text":"Officials are looking to forge consensus on how and when to eventually reduce their asset purchases\nFed Chairman Jerome Powell, who spoke at a Senate committee hearing earlier this month, has promised ample notice before reducing purchases of securities.\nFederal Reserve officials are set to resume deliberations Wednesday about how and when to begin paring their asset purchases amid an economic rebound clouded by supply-chain bottlenecks and rising Covid-19 cases.\nThe central bank at the end of last year said it would continue to purchase $120 billion in Treasurys and mortgage-backed securities monthly until officials deemed they had achieved “substantial further progress” toward their goals of low unemployment and inflation reaching their 2% goal.\nThe Fed will release its policy statement at 2 p.m. EDT. Most of the focus is likely to center on Chairman Jerome Powell’s news conference at 2:30 p.m. Here’s what to watch:\nTaper timing\nOfficials are likely to receive a formal staff briefing around when to start paring their monthly purchases of $80 billion in Treasury securities and $40 billion in mortgage securities, and how quickly to reduce, or taper, them.\nThe Fed began buying large quantities of the securities in March 2020, when the Covid-19 pandemic triggered a near-meltdown in financial markets. With the Fed’s short-term interest rate at zero, the purchases are designed to provide additional stimulus by holding down long-term interest rates.\nSome officials are concerned that a burst of inflation this year from bottlenecks associated with reopening the economy will prove more durable than previously anticipated. These policy makers are eager to start the taper, in part because they and their colleagues have said they aren’t likely to consider raising interest rates from near zero until they are done tapering the asset purchases.\nAnother camp thinks recent price pressures will subside and could leave the Fed in the same position that it faced for much of the past decade, in which global forces kept inflation below 2% even with historically low interest rates. They are worried that accelerating plans to wind down the asset purchases could raise questions among investors about the Fed’s commitment to achieving its economic goals.\nBecause Mr. Powell has pledged to provide ample notice to financial markets before the Fed starts tapering to avoid catching investors by surprise, the central bank looks unlikely to start the process now or at its next meeting in September. Mr. Powell’s press conference will be heavily scrutinized for clues on how officials judge recent economic progress. In April, he said the Fed was “a long way from” its tapering goals, and he characterized the economy as “still a ways off” from them in June.\nPurchase pace\nOfficials also must consider the pace of any reductions. Some officials have discussed concluding the purchases around October 2022 so they could lift rates soon thereafter if the recovery is stronger or inflation is higher than now anticipated.\nDuring a prior asset-purchase program that ended in 2014, the Fed shrank its purchases in modest, equal amounts over the course of 10 months. It then waited another 14 months before raising interest rates.\nAnother tactical question centers on whether to reduce the pace of Treasurys and mortgage-backed securities equally. Some officials have raised concerns about rising home prices and are pressing to stop purchases of mortgage bonds sooner.\nBut Mr. Powell and other officials have poured cold water on those concerns in recent weeks. They have said mortgage buying, by purchasing longer-dated assets, provides a way to more broadly stimulate the economy and isn’t focused squarely on housing markets.\n“If the housing market has you really worried, that’s an argument for just tapering everything sooner and faster,” said William English, a former senior Fed economist who is now a professor at the Yale School of Management.\nInflation outlook\nFor a third straight month in June,inflation ran hotter than many economists had expected. The Labor Department’s consumer-price index increased 5.4% from a year ago, the highest 12-month rate since August 2008.\nMr. Powell said two weeks ago that many of the elevated price pressures can still be traced to goods and services affected by supply-chain bottlenecks and other pandemic-driven upheaval. As a result, he said it would be too soon for the Fed to abandon its earlier expectation that prices will return to their 2% target on their own and to raise rates to cool down demand and reduce inflation faster.\nBut Mr. Powell could face questions over how long the central bank and its 12-member rate-setting committee feels it would take to revisit their projections. Price pressures in some sectors of the economy where inflation had been subdued over the past year, including residential rents, have picked in recent months.\nDelta variant\nMr. Powell is also likely to be pressed on how the recent increase in Covid-19 cases among unvaccinated populations could reshape the central bank’s growth forecasts for the rest of the year. While a return to shutdowns and other state-mandated restrictions on activity seem less likely than a year ago, increased hesitancy on the part of consumers to return to normal spending routines could complicate the economic outlook.\nSince Fed officials last met in June, government-bond prices have jumped, a sign that investors are less confident about long-term growth prospects and less worried about inflation.\nYields, which rise when bond prices fall, climbed sharply earlier in the year, lifted by expectations that vaccinations and fiscal stimulus would spur an economic boom. After hitting a 13-month high of 1.75% at the end of March, the 10-year Treasury yield has declined—to 1.57% on June 16, after the Fed concluded its previous meeting, and to 1.24%, a five-month low, when the Fed’s meeting began on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174983815,"gmtCreate":1627057811137,"gmtModify":1633768340277,"author":{"id":"3577258181360086","authorId":"3577258181360086","name":"Caydron","avatar":"https://static.tigerbbs.com/04231ea65b6a07c125cc1deaf560bfbc","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577258181360086","authorIdStr":"3577258181360086"},"themes":[],"htmlText":"Looks good","listText":"Looks good","text":"Looks good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/174983815","repostId":"2153998479","repostType":4,"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}